STOCK TITAN

Brand Engagement Network reports FY2025 control weakness

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-K/A

Rhea-AI Filing Summary

Brand Engagement Network Inc. amended its 2025 annual report to add management’s internal-control report and Part III disclosures. Management concluded that disclosure controls and internal control over financial reporting were not effective as of December 31, 2025, due to a material weakness, citing a lack of documented controls, insufficient accounting staff with U.S. GAAP and SEC reporting expertise, and insufficient segregation of duties. It said the original annual report’s consolidated financial statements fairly present the company’s financial position, results and cash flows in all material respects. Management also said its 2023 and 2024 annual reports were not timely filed and materially deficient; neither has been amended.

During 2026, the company enhanced reviews of journal entries, reconciliations and disclosures, added dual-control review in South Korea, strengthened related-party procedures and hired a human resources director. Full remediation procedures are still being developed; ongoing measures include accounting recruitment, control documentation, equity-administration systems, Audit Committee oversight and testing. The board has nine seats, five filled and four vacant; when the original report was filed, the company said it did not meet Nasdaq audit- and compensation-committee composition requirements.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointBNAI’s material weakness left controls ineffective at December 31, 2025.

Filing Explained

The filing reports 15,546 salary shares issued to Tyler Luck and 14,904 to Walid Khiari; the broader award pool remains capacity, not issuance.

The 2024 LTIP authorized 275,930 shares for awards at its effective date; this is capacity for awards, not evidence those shares were issued.

With Board approval, the pool may increase by up to 5% of shares outstanding on the first trading date of each calendar year, subject to a 15% ceiling based on shares outstanding at the plan’s effective date.

The filing reports that 15,546 shares were issued to CEO Tyler Luck and 14,904 to CFO/COO Walid Khiari in lieu of 2025 salary; these issuances increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

Tyler Luck, Chief Executive Officer and Director — total compensation $180,750 Fiscal 2025
Paul Chang, former Chief Executive Officer — total compensation $248,052 Fiscal 2025
Janine Grasso, former Interim Chief Executive Officer — total compensation $70,997 Fiscal 2025
Walid Khiari, Chief Financial Officer and Chief Operating Officer — total compensation $400,500 Fiscal 2025
James D. Henderson, Jr., Corporate Secretary and General Counsel — total compensation $180,000 Fiscal 2025
Venkata Ramana Pinnam, Director of Cybersecurity and Quality Assurance — total compensation $201,500 Fiscal 2025
Board seats 9 total; 5 filled; 4 vacant Board composition described in the report
Common shares issued and outstanding 5,857,955 shares As of April 15, 2026
material weakness regulatory
"due to the existence of a material weakness"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
disclosure controls and procedures regulatory
"effectiveness of our disclosure controls and procedures"
Policies, routines and internal checks a public company uses to identify, collect and verify information that must appear in its financial reports and public filings, and to make sure that material news is disclosed accurately and on time. Investors care because effective controls increase confidence that the company’s reported numbers and disclosures are reliable and reduce the risk of surprises, much like a building’s inspection and alarm system helps occupants trust the structure’s safety.
internal control over financial reporting financial
"effectiveness of our internal control over financial reporting"
Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.
Internal Control – Integrated Framework (2013) technical
"criteria set forth in Internal Control – Integrated Framework (2013)"
segregation of duties technical
"a lack of sufficient segregation of duties"
Segregation of duties is the practice of splitting important financial and operational tasks among different people so no single person can both start, approve, and record the same transaction — like having one person ring up sales and another person deposit the money. For investors, it matters because this simple separation reduces the chance of mistakes or fraud, helps ensure financial reports are trustworthy, and lowers legal and reputation risk that can affect a company’s value.
Rule 10A-3 regulatory
"independence criteria of Rule 10A-3"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What internal-control weakness did BNAI report?

Management concluded controls were not effective as of December 31, 2025, due to a lack of properly documented internal controls, insufficient accounting personnel with U.S. GAAP and SEC reporting expertise, and insufficient segregation of duties.

What remediation is BNAI still undertaking?

Ongoing measures include recruiting accounting personnel and documenting controls, improving equity-transaction tracking, implementing an automated equity-administration and cap-table system, enhancing Audit Committee oversight and finance training, and establishing monitoring and testing.

Why did BNAI report committee-composition noncompliance?

At the time the original report was filed, Ruy Carrasco, M.D., an executive officer, chaired the Audit Committee with directors Jon Leibowitz and Richard Isaacs, M.D.; the company said it did not meet Nasdaq composition requirements and Rule 10A-3. The Compensation Committee then included Dr. Carrasco and director Thomas Morgan Jr., had no chair, and did not meet Nasdaq composition requirements.

What was BNAI CEO Tyler Luck’s 2025 total compensation?

Tyler Luck, the Chief Executive Officer, had reported total compensation of $180,750 for 2025, comprising $180,000 in salary and $750 in other compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
true FY 0001838163 0001838163 2025-01-01 2025-12-31 0001838163 BNAI:CommonStockParValue0.0001PerShareMember 2025-01-01 2025-12-31 0001838163 BNAI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf115.00PerShareMember 2025-01-01 2025-12-31 0001838163 2025-06-30 0001838163 2026-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

(Amendment No. 1)

 

(Mark One)

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the annual period ended December 31, 2025

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission file number 001-40130

 

Brand Engagement Network Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   98-1574798
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

300 Delaware Ave    
Suite 210    
Wilmington, DE   19801
(Address of Principal Executive Offices)   (Zip Code)

 

(307) 757-3650

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   BNAI   The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $115.00 per share

  BNAIW   The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Exchange Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company ☒
    Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

 

Yes ☐ No ☒

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2025, (the last business day of the registrant’s most recently completed second fiscal quarter), based on the Post-Split $4.40 closing price as of such date was approximately $19,272,654.

 

On December 12, 2025, the registrant effected a 1-for-10 reverse stock split. All share and per-share amounts in this report have been retroactively adjusted to reflect the reverse stock split, except for the public float calculation above, which is presented on a pre-split basis as of the June 30, 2025 measurement date required by the Form 10-K instructions.

 

As of April 15, 2026, 5,857,955 shares of the Issuer’s common stock, $0.0001 par value per share, and 1,644,096 public warrants representing the right to acquire one share of the Issuer’s common stock were valued at approximately $115.00, were issued and outstanding.

 

 

 

 
 

 

EXPLANATORY NOTE

 

This Amendment No. 1 to Form 10-K of Brand Engagement Network Inc., referred to in this report as the “Company,” “we,” “us” or “our,” is being filed solely:

 

(i)to amend and restate Part II, Item 9A to include management’s report on internal control over financial reporting and to reflect deficiencies in disclosure controls and procedures relating to the same and other items that are the subject matter of this Amendment No. 1;

 

(ii)to amend and restate Part III, Item 10 to correct and update certain information regarding corporate governance, director independence and delinquent Section 16(a) reports including, among other things: (A) correcting the prior independence determination of our board of directors (the “Board”) with respect to Ruy Carrasco to reflect that his executive officer status precluded a finding of independence under Nasdaq Listing Rule 5605(a)(2); (B) correcting the disclosure regarding the composition of the Audit Committee to indicate that it did not comply with Nasdaq Listing Rule 5605(c)(2) because a director serving on the committee was not independent under Nasdaq Listing Rule 5605(a)(2) and also did not meet the criteria for independence under Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”); (C) correcting the disclosure regarding the composition of the Compensation Committee to indicate that it did not comply with Nasdaq Listing Rule 5605(d)(2) because a director serving on the committee was not independent under Nasdaq Listing Rule 5605(a)(2); and (D) updating the disclosure regarding delinquent Section 16(a) reports to add additional late filings;

 

(iii)to amend and restate Part III, Item 11 to correct and update certain information regarding executive compensation and director compensation, including, among other things: (A) correcting the Company’s named executive officers for the year ended December 31, 2025 and accordingly updating the Summary Compensation Table, the Outstanding Equity Awards at 2025 Fiscal Year End table, and related narrative descriptions; and (B) correcting and updating the Non-Employee Director Compensation Table to include former director Christopher Gaertner and also to add certain additional compensation received by directors in 2025;

 

(iv)to amend and restate Part III, Item 12 to correct and update the beneficial ownership table, to add additional security holders, including certain named executive officers, and to provide related information, among other things;

 

(v)to amend and restate Part III, Item 13 to correct and update certain information regarding related party transactions and our policies and procedures for approving related party transactions including, among other things: (A) transactions and arrangements with additional related parties including, but not limited to, Michael Lucas, the spouse of Tyler Luck, our President and Chief Executive Officer, and affiliated entities; entities affiliated with Blake Lucas, the step-son of Mr. Luck; and entities affiliated with Shawn Lucas, the brother-in-law of Mr. Luck; (B) additional financing transactions involving related parties, including, but not limited to, private placements in May 2024, August 2024, January 2025 and January 2026; (C) loans to the Company from entities affiliated with Thomas Morgan Jr.; (D) conversions of debt held by related parties or other amounts owed to related parties into shares of the Company’s common stock; (E) the assignment to us by related parties of litigation claims in satisfaction of certain financing obligations of such related parties; (G) registration rights held by related parties; and (H) the Company’s failure to conduct appropriate review and oversight of related party transactions for potential conflict of interest situations on an ongoing basis by the Company’s Audit Committee or another independent body of the Board, as required by Nasdaq Listing Rule 5630, including as a result of failing to comply with previously disclosed policies and procedures for approving related party transactions; and

 

(vi)to amend and restate Part IV, Item 15 to correct and update the table of exhibits to include certain omitted exhibits that are required to be filed.

 

2

 

 

As required by Rule 12b-15, in connection with this Amendment No. 1, the Company’s Principal Executive Officer and Principal Financial Officer are providing new Rule 13a-14 certifications. Because no financial statements have been included in this Amendment No. 1, paragraph 3 of the certifications has been omitted. Additionally, because no financial statements are contained within this Amendment No. 1, the Company has not included new certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

Except as explicitly set forth herein, this Amendment No. 1 does not purport to modify or update the disclosures in, or exhibits to original Form 10-K (the “Original Filing”), or to update the Original Filing to reflect events occurring after the date of such filing.

 

Item 9A. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Prior to the Original Filing, management, with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (“SEC”). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.

 

Based on such evaluation of our disclosure controls and procedures as of December 31, 2025, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were not effective due to a material weakness in our internal control over financial reporting, as described below under “Management’s Report on Internal Control over Financial Reporting.”

 

In connection with the preparation and filing of this Amendment No. 1, our Chief Executive Officer and Chief Financial Officer re-evaluated the effectiveness of the design and operation of our disclosure controls and procedures, taking into account the errors summarized in the Explanatory Note to this Amendment No. 1. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of December 31, 2025, our disclosure controls and procedures were not effective due to the aforementioned material weakness, the omission in Part II, Item 9A of the Original Filing of management’s report on internal control over financial reporting, incomplete corporate records, and a lack of effective processes relating to the preparation and review of: (i) the corporate governance, director independence and delinquent Section 16(a) report disclosures required by Part III, Item 10 of Form 10-K; (ii) the executive compensation and director compensation disclosures required by Part III, Item 11 of Form 10-K; (iii) the beneficial ownership disclosures required by Part III, Item 12 of Form 10-K; (iv) the related party transaction disclosures required by Part III, Item 13 of Form 10-K; and (v) the exhibit filings required by Part IV, Item 15 of Form 10-K.

 

The Chief Executive Officer and Chief Financial Officer also considered that our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (“2023 Annual Report”), filed on April 1, 2024, was not timely filed and was materially deficient because it failed to include, and was not amended to include, required Part III information, and that our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (“2024 Annual Report”), filed on March 31, 2025, was not timely filed and was materially deficient because it omitted management’s report on internal control over financial reporting. Although we are filing this Amendment No. 1 to the Original Filing to address, among other things, the omission of management’s report on internal control over financial reporting, no amendments have been filed to the 2023 Annual Report or 2024 Annual Report.

 

We are implementing additional operational procedures designed to ensure the effectiveness of our disclosure controls and procedures with respect to future reports that we file with or submit to the SEC under the Exchange Act.

 

Notwithstanding the foregoing, giving full consideration to the aforementioned material weakness, we have concluded that the consolidated financial statements included in the Original Filing present fairly, in all material respects, our financial position, the results of our operations and our cash flows for each of the periods presented in conformity with U.S. generally accepted accounting principles

 

3

 

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining effective internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial reporting is a process designed by and under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, and effected by our management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

 

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2025, using the criteria set forth in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

Based on the results of this evaluation, our management concluded that our internal control over financial reporting was not effective as of December 31, 2025, due to the existence of a material weakness as described below. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements may not be prevented or detected on a timely basis.

 

Management has determined that a material weakness in internal control over financial reporting existed as of December 31, 2025 due to the existence of the following identified deficiencies:

 

●A lack of a properly documented internal control system in accordance with the requirements of COSO or some similarly appropriate internal control methodology or formal documentation of our systems of internal control.
●A lack of sufficient accounting personnel with the requisite knowledge of US GAAP and financial reporting requirements of the SEC; and
●A lack of sufficient segregation of duties in the financial reporting process.

 

This material weakness creates a reasonable possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis.

 

Plan for Remediation of Material Weakness

 

Remediation of Material Weakness

 

As previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025, management identified a material weakness in our internal control over financial reporting related to insufficient resources and expertise in our accounting and financial reporting functions to prepare timely, U.S. GAAP-compliant financial statements and to adequately document risks and related controls.

 

As of this Amendment No. 1, we are still developing and documenting the full extent of the procedures to implement and remediate the material weakness described above.

 

Completed Remediation Actions

 

During 2026 and through the date of this Amendment, we have taken the following steps to address the material weakness:

 

●Enhanced the review process over material journal entries, account reconciliations, and financial statement disclosures, including additional levels of review by qualified personnel and external advisors.
●Implemented dual-control (“four eyes”) review procedures in our South Korea operations.
●Strengthened related-party identification and disclosure procedures.
●Hired a human resources director to strengthen personnel oversight and support segregation of duties.

 

4

 

 

Ongoing Remediation Efforts

 

Management is continuing to implement additional measures to remediate the material weakness, including:

 

●Recruiting and onboarding additional accounting personnel with public-company GAAP and SEC reporting experience to improve segregation of duties and internal technical capability.
●Completing a formal risk-and-control matrix and documenting key controls over significant accounts and disclosures.
●Implementing improved tracking and documentation procedures for equity-related transactions, including shares, warrants, options, and LTIP awards.
●Fully implementing an automated equity administration and cap-table system to reduce reliance on manual reconciliations.
●Enhancing Audit Committee oversight procedures and providing additional training to finance personnel on public-company reporting requirements and the Company’s control framework.
●Establishing ongoing monitoring and testing procedures to evaluate the operating effectiveness of remediated controls.

 

Changes in Internal Control over Financial Reporting

 

Other than the changes made in respect of the material weakness described above, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Disclosure Controls and Procedures

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and implemented, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues within a company are detected. The inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

No Attestation Report of Registered Public Accounting Firm

 

This Amendment No. 1 does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the SEC.

 

5

 

 

Part III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

The following table sets forth information about our directors and executive officers as of April 15, 2026:

 

Name   Age   Position
Executive Officers        
Tyler J. Luck   34   Chief Executive Officer and Co-Founder
Walid Khiari   51   Chief Financial Officer and Chief Operating Officer
Ruy Carrasco, M.D.   54   Chief Medical Informatics Officer
James D. Henderson, Jr.   57   Corporate Secretary and General Counsel
Patrick O. Nunally   63   Chief Scientist, Co-Chief Technology Officer and Co-Founder
Venkata Ramana Pinnam   58   Director of Cybersecurity and Quality Assurance
         
Directors        
Tyler J. Luck   34   Director
Jon Leibowitz   68   Chairman of the Board
Thomas Morgan Jr.   64   Director
Ruy Carrasco, M.D.   54   Director
Richard Isaacs, M.D.   63   Director

 

The biographies of the above-identified individuals are set forth below:

 

Tyler J. Luck - Chief Executive Officer and Director

 

Mr. Luck is a co-founder of BEN and has served as our Chief Executive Officer since September 2025, initially as Acting Chief Executive Officer, and as a member of our Board of Directors since the closing of the Business Combination on March 2024. Mr. Luck served as President and Chief Product Officer of BEN from 2018 until September 2025. Mr. Luck’s familiarity with the day-to-day operations of the company makes him well qualified to serve on our Board of Directors.

 

Walid Khiari - Chief Financial Officer and Chief Operating Officer

 

Mr. Khiari joined BEN in November 2024 and currently serves as Chief Financial Officer and Chief Operating Officer of BEN. Mr. Khiari has over twenty years of experience in finance, including technology banking, during which time he worked with software companies of various sizes from startups to large, publicly-traded corporations. Prior to joining the Company, Mr. Khiari served as the Managing Director of Technology, Media and Telecommunications at Houlihan Lokey from 2021 to 2023, as the Managing Director of Technology Investment Banking at Rothschild & Co. from 2017 to 2020, and as the Director of Technology Investment Banking at Credit Suisse from 2012 to 2017. Mr. Khiari also served as the Vice President of Technology Investment Banking at Merrill Lynch from 2007 to 2012. Mr. Khiari’s appointment brings to the Company significant experience in capital raising, mergers and acquisitions and strategic planning. Mr. Khiari graduated from the University of Paris Pantheon-Sorbonne with honors and received his MBA from the Wharton School at the University of Pennsylvania.

 

Ruy Carrasco, M.D. - Chief Medical Informatics Officer and Director

 

Dr. Carrasco joined BEN in May 2021 and has served as a member of our Board of Directors since September 2025. Since August 2018, Dr. Carrasco has also served as Managing Partner at Child Neurology Consultants Austin. In addition, Dr. Carrasco served as a Member of the American College of Rheumatology within the Registries and Health Information Technology division from November 2016 to November 2019. Dr. Carrasco served as Chief Medical Information Officer for Presbyterian Healthcare Services from August 2018 to July 2019 and for Seton Family of Hospitals from August 2014 through August 2018. Dr. Carrasco earned his Doctor of Medicine (M.D.) degree from the University of New Mexico and Bachelor of Arts degree from Baylor University. Dr. Carrasco’s experience in clinical medicine and medical informatics, and his knowledge of our health-care related products, make him well qualified to serve on our Board of Directors.

 

6

 

 

James D. Henderson, Jr. - Corporate Secretary and General Counsel

 

Mr. Henderson joined Prior BEN in April 2018 as its Corporate Secretary, General Counsel and a director until March 13, 2024, and has served as our Corporate Secretary and General Counsel since the closing of the Business Combination. Since 2002, Mr. Henderson has also served as an attorney at the Law Offices of James D. Henderson, Jr. Mr. Henderson earned his Juris Doctor degree from the Arizona State College of Law and his Bachelor of Arts in Political Science from Arizona State University.

 

Patrick O. Nunally - Chief Scientist, Co-Chief Technology Officer and Co-founder

 

Mr. Nunally is Chief Scientist Emeritus and co-founded BEN in April 2018. Mr. Nunally has also served as Chief Technology Officer at Raise a Hood, Inc. from 2021 to 2023 and has served and currently serves as Partner of LionCompass LLC since 2019. Mr. Nunally earned his Bachelor of Science in Electronics Engineering from California Polytechnic State University-San Luis Obispo.

 

Venkata Ramana Pinnam - Director of Cybersecurity and Quality Assurance

 

Mr. Pinnam joined BEN in February 2021 as an advisor and has served as our Director of Cybersecurity and Quality Assurance since June 1, 2026. Prior to joining BEN, Mr. Pinnam recently served as Director of Engineering at Curantis Solutions from June 2021 to October 2022, Global Program Director of Engineering from October 2019 to January 2021 independent consultant for various companies and as Senior Director of Product Management and Engineering Delivery at rfxcel Corp. from September 2016 to September 2019. Mr. Pinnam earned his MBA in Strategic Management from the University of Wisconsin and his Bachelor of Science in Mechanical Engineering from Andhra University.

 

Jon Leibowitz - Director and Chairman of the Board

 

Mr. Leibowitz has served as a member of our Board of Directors since March 2024, and as Chairman of the Board since April 2026. Mr. Leibowitz serves as the Chairman of the Board of the National Consumers League, America’s oldest consumer advocacy organization. Previously, Mr. Leibowitz was a senior partner at Davis Polk & Wardwell LLP from 2013 to 2021, where his practice focused on complex antitrust aspects of mergers and acquisitions, as well as government and private antitrust investigations and litigation. Prior to private practice, Mr. Leibowitz served in executive positions at the Federal Trade Commission (the “FTC”), both as Commissioner from 2004 to 2009, and as Chairman from 2009 to 2013. During his tenure at the FTC, Mr. Leibowitz focused on antitrust, consumer privacy and unfair competition matters, particularly in the pharmaceutical and technology industries, as well as privacy legislation and antitrust reform. From 1991 to 2000, Mr. Leibowitz served on various United States Senate subcommittees, including the Antitrust Subcommittee, the Subcommittee on Terrorism and Technology and the Subcommittee on Juvenile Justice. Mr. Leibowitz received his J.D. from New York University School of Law and holds a B.S. from the University of Wisconsin. Mr. Leibowitz’s experience provides him with significant insight regarding mergers and acquisitions, consumer privacy and technology issues, as well as complex antitrust matters and related legislation. We believe Mr. Leibowitz’s background and expertise in these matters make him well qualified to serve on our Board of Directors.

 

Thomas Morgan Jr. - Director

 

Mr. Morgan has served as a member of our Board of Directors since March 2024. Mr. Morgan is the founder and Chief Executive Officer of Corps Capital Advisors LLC, an investment advisory firm, which he founded in July 2019. Prior to the closing of the Business Combination, Mr. Morgan served as Co-Chief Executive Officer of DHC Acquisition Corp., our predecessor, from March 2021 until March 2024, and was a member of DHC Sponsor, LLC. Previously, Mr. Morgan served as a Managing Director at Morgan Stanley, a large investment bank, from 2009 to July 2019. Mr. Morgan began his career in private wealth management at Goldman Sachs in 1993. Prior to his professional career, Mr. Morgan served as an infantry/aviation officer in the US Army with the 2nd Infantry Division, 1st Cavalry Division, 6th Cavalry Squadron. Mr. Morgan received his B.S. from the United States Military Academy and his MBA from Harvard University. Mr. Morgan’s significant investment and financial expertise make him well qualified to serve as a member of our Board of Directors.

 

7

 

 

Richard Isaacs, M.D. - Director

 

Dr. Isaacs has served as a member of our Board of Directors since August 26, 2024, and was appointed in connection with the Securities Purchase Agreement, dated August 26, 2024, between the Company and certain investors described in Item 13 under “August 2024 Private Placement”. Dr. Isaacs has more than 34 years of experience in the medical field and currently serves as the Dean of the College of Medicine and Senior Vice President of Medical Affairs and Chief Academic Officer at California Northstate University College of Medicine. Prior to his current role, Dr. Isaacs has served with the California Northstate University College of Medicine since June 2015, including as a professor of otolaryngology. From June 2017 to May 2023, Dr. Isaacs served as the Chief Executive Officer and a Director of The Permanente Medical Group, Inc., President and Chief Executive officer of The MidAtlantic Permanente Medical Group, P.C. and Co-Chief Executive Officer of The Permanente Federation, LLC. Dr. Isaacs served as Physician-in-Chief and Chief-of-Staff of Kaiser Permanente Medical Center from April 2005 to June 2017 and served as the Chair of the Head and Neck Surgery Chiefs Group from January 2001 to March 2005. Dr. Isaacs received his B.S. from the University of Michigan and his M.D. at Wayne State University School of Medicine. Dr. Isaacs’s significant background in the medical field and experience with healthcare and medical technology well qualifies him to serve on our Board.

 

Family Relationships

 

There are no family relationships among any of our directors or executive officers.

 

Board of Directors

 

Our board of directors is fixed at nine (9) seats, five of which are filled with four director seats remaining vacant. Our Board is divided into three classes, each serving staggered, three-year terms and the current active board of directors is as follows:

 

  ● our Class I directors are Thomas Morgan Jr. and Dr. Ruy Carrasco, with one director seat remaining vacant;
  ● our Class II directors are Jon Leibowitz and Dr. Richard Isaacs, with one director seat remaining vacant; and
  ● our Class III director is Tyler Luck, with two director seats remaining vacant.

 

At the 2025 annual meeting of stockholders, the terms of the Class I directors expired, and Class I directors were selected for a full three-year term. At the 2026 annual meeting of stockholders, the terms of the Class II directors will expire and Class II directors will be elected for a full three-year term. At the 2027 annual meeting of stockholders, the terms of the Class III directors will expire, and Class III directors will be elected for a full three-year term. At each succeeding annual meeting, directors of the class whose terms expire at such annual meeting.

 

Director Independence

 

Nasdaq listing rules require that a majority of the board of directors of a company listed on Nasdaq be composed of “independent directors,” which is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship, which, in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director.

 

In connection with this Amendment, our board of directors re-evaluated the independence of each of our directors as of the date of the Original Filing. Based on such reevaluation, our board of directors determined that each of Richard Isaacs, M.D., Jon Leibowitz and Thomas Morgan Jr, representing three of our five directors, does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is an “independent director” as defined under the listing standards of Nasdaq. Tyler J. Luck is not considered an independent director because of his position as our Chief Executive Officer. With respect to Dr. Carrasco, our board of directors considered that Dr. Carrasco was not independent at the time of the Original Filing because he was an executive officer. With respect to the determination of independence for Mr. Morgan, our board of directors considered Mr. Morgan’s service as an officer of DHC Acquisition Corp. prior to the Business Combination, for which he did not receive compensation, his interest in DHC Sponsor, LLC, and the transactions between the Company and entities managed by Mr. Morgan described in Item 13.

 

8

 

 

Committees of the Board of Directors

 

The standing committees of our board of directors consist of an Audit Committee, a Compensation Committee, and a Nominating and Corporate Governance Committee. The composition of each committee is set forth below.

 

Audit Committee

 

The Audit Committee’s primary responsibilities include, among other things:

 

  ● overseeing management’s establishment and maintenance of adequate systems of internal accounting and financial controls;
  ● overseeing the effectiveness of our legal and regulatory compliance programs;
  ● overseeing our financial reporting process, including the filing of financial reports; and
  ● selecting independent auditors, evaluating their independence and performance and approving audit fees and services performed by them.

 

Our Audit Committee consisted of Jon Leibowitz, Ruy Carrasco, and Richard Isaacs at the time this report was initially filed. Our board of directors has determined that Mr. Leibowitz and Dr. Isaacs are independent directors under the listing standards of Nasdaq, satisfy the independence criteria of Rule 10A-3 under the Exchange. Dr. Carrasco, who served as chair of the Audit Committee at the time this report was initially filed, was not eligible to serve on the Audit Committee because he was an executive officer of the Company and, as a result, did not satisfy the independence requirements of the listing standards of Nasdaq or Rule 10A-3. Accordingly, at the time this report was initially filed, the Company was not in compliance with the audit committee composition requirements of the listing standards of Nasdaq and Rule 10A-3. Our board of directors has determined that Jon Leibowitz qualifies as an “audit committee financial expert,” as defined under rules and regulations of the SEC.

 

Compensation Committee

 

The Compensation Committee’s responsibilities include, among other things:

 

  ● ensuring that our executive compensation programs are appropriately competitive, supporting organizational objectives and stockholder interests and emphasizing pay-for-performance linkage;
  ● evaluating and approving compensation and setting performance criteria for compensation programs for our chief executive officer and other executive officers; and
  ● overseeing the implementation and administration of our compensation plans.

 

Our Compensation Committee consisted of Dr. Ruy Carrasco and Thomas Morgan at the time this report was initially filed. Our board of directors has determined that Mr. Morgan is an independent director under the listing standards of Nasdaq. Dr. Carrasco was not eligible to serve on the Compensation Committee because he was an executive officer of the Company and, as a result, was not an independent director under the listing standards of Nasdaq. Accordingly, at the time this report was initially filed, the Company was not in compliance with the compensation committee composition requirements of the listing standards of Nasdaq. At the time this report was initially filed, there was no chairman of the Compensation Committee.

 

Nominating and Corporate Governance Committee

 

The Nominating and Corporate Governance Committee’s responsibilities include, among other things:

 

  ● recommending director nominees for our board of directors and its committees;
  ● recommending the size and composition of our board of directors and its committees;
  ● reviewing our corporate governance guidelines and proposed amendments to our Charter and Bylaws; and
  ● reviewing and making recommendations to address stockholder proposals.

 

9

 

 

Our Nominating and Corporate Governance Committee consists of Richard Isaacs and Jon Leibowitz, each of whom is an independent director under Nasdaq’s listing standards. Jon Leibowitz serves as the chair of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee is responsible for overseeing the selection of persons to be nominated to serve on our board of directors. The Nominating and Corporate Governance Committee considers persons identified by its members, management, stockholders, investment bankers and others.

 

There have been no material changes to the procedures by which our stockholders may recommend nominees to our board of directors since we last described those procedures in our proxy statement for our 2025 annual meeting of stockholders.

 

Code of Business Conduct and Ethics

 

Our board of directors has adopted a Code of Business Conduct and Ethics for our directors, officers, employees and certain affiliates in accordance with applicable federal securities laws, a copy of which is available on BEN’s website https://beninc.ai/ under “Investors: Corporate Governance.” BEN will make a printed copy of the Code of Business Conduct and Ethics available to any stockholder who so requests. Requests for a printed copy may be directed to our General Counsel, James D. Henderson, Jr., at legal@beninc.ai.

 

If we amend or grant a waiver of one or more of the provisions of our Code of Business Conduct and Ethics, we intend to satisfy the requirements under Item 5.05 of Form 8-K regarding the disclosure of amendments to or waivers from provisions of our Code of Business Conduct and Ethics that apply to our principal executive officer, principal financial officer and principal accounting officer by posting the required information on BEN’s website at https://beninc.ai/. The information on this website is not part of this Amendment.

 

Insider Trading Policy

 

Our board of directors has adopted an insider trading policy governing the purchase, sale and/or other dispositions of its securities by directors, officers and certain employees that is reasonably designed to promote compliance with insider trading laws, rules and regulations. Our insider trading policy is available on BEN’s corporate website, https://beninc.ai/ under “Investors: Corporate Governance.” A copy of our insider trading policy is filed as Exhibit 19.1 to the Original Filing.

 

Whistleblower Policy

 

Our board of directors has adopted a whistleblower policy to provide employees with a confidential and anonymous method for reporting concerns about the conduct of the Company or employees free from retaliation. Our whistleblower policy is available on BEN’s corporate website, https://beninc.ai/ under “Investors: Corporate Governance.”

 

Compensation Recovery Policy

 

Our board of directors has adopted a compensation recovery policy, in accordance with Rule 10D-1 under the Exchange Act and Nasdaq Rule 5608, which requires the Company to recover erroneously awarded incentive-based compensation received by current and former executive officers in the event the Company is required to prepare an accounting restatement. Our compensation recovery policy is available on BEN’s corporate website, https://beninc.ai/ under “Investors: Corporate Governance.”

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our officers and directors, and persons who beneficially own more than 10% of a registered class of our equity securities, to file reports of ownership and changes of ownership with the SEC. Based solely on a review of copies of the reports filed with the SEC during, and with respect to, the last fiscal year, and written representations from reporting persons, we believe that, during the last fiscal year, all filing requirements under Section 16(a) applicable to our officers, directors and 10% stockholders were timely met, except that (i) Tyler J. Luck and October 3rd Holdings, LLC jointly filed one late report relating to two transactions and did not file two reports relating to two transactions; (ii) Venkata Ramana Pinnam filed one late report relating to one transaction and did not file 1 report relating to 1 transaction; (iii) Walid Khiari did not file 1 report relating to 1 transaction; (iv) James D. Henderson, Jr. did not file three reports relating to three transactions; (v) Thomas Morgan Jr. did not file seven reports relating to seven transactions; (vi) October 3rd Holdings, LLC, which has beneficially owned more than 10% of our common stock since March 14, 2024, did not file a Form 3;

 

10

 

 

Item 11. Executive Compensation

 

We are an “emerging growth company,” as defined in the JOBS Act, and are also a “smaller reporting company” under SEC rules. As such, we have opted to comply with the scaled executive compensation disclosure rules applicable to emerging growth companies and smaller reporting companies, which provide certain exemptions from various reporting requirements that are applicable to other public companies. Unless stated otherwise or the context otherwise requires, in this section the terms the “Company,” “we,” “us,” “our,” and “Prior BEN” refer to the Company prior to the Business Combination and the Company and its predecessors following the Business Combination.

 

Prior to the consummation of the Business Combination on March 14, 2024, we were a private company. As a result, the compensation awarded to, earned by, or paid to our directors and named executive officers for the portion of the fiscal year ended December 31, 2024 prior to the closing of the Business Combination was largely provided by and determined in accordance with policies and practices developed by our board of directors (the “Board”) prior to the Business Combination. Compensation matters with respect to the post-Closing combined company have been and will be reviewed and implemented by the Board and/or by the Compensation Committee, as applicable.

 

Introduction

 

To achieve our goals, we have designed our compensation and benefits program to attract, retain, incentivize and reward deeply talented and qualified executives who share its philosophy and desire to work towards achieving our goals. We believe our compensation program should promote our success and align executive incentives with the long-term interests of its stockholders. Our current compensation arrangements consist principally of a base salary, an annual cash incentive bonus and equity compensation, as described below.

 

The Board determines compensation of our executive officers. For the year ended December 31, 2025, our named executive officers (“Named Executive Officers” or “NEOs”) were as follows:

 

●Tyler Luck, Chief Executive Officer
●Paul Chang, Former Chief Executive Officer
●Janine Grasso, Former Interim Chief Executive Officer
●Walid Khiari, Chief Financial Officer and Chief Operating Officer
●James D. Henderson, Jr., Corporate Secretary and General Counsel
●Venkata Ramana Pinnam, Director of Cybersecurity and Quality Assurance

 

This section provides an overview of our executive compensation arrangements with each named executive officer, including a narrative description of the material factors necessary to understand the information disclosed in the summary compensation table below. This section may contain forward-looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs.

 

11

 

 

Summary Compensation Table

 

The following table sets forth information concerning the compensation of the named executive officers for the fiscal years ended December 31, 2024 and 2025.

 

Name and principal position Year 

Salary

($)

  

Bonus

($)

  

Stock Awards

($)1

  

Option Awards

($)2

  

Non-Equity Incentive Plan Compensation

($)

  

Nonqualified Deferred Compensation Earnings

($)

  

All Other Compensation

($)

  

Total

($)

 
Tyler Luck,  2025  $180,000(4)   –    –(5)   –    –    –    750(6)   180,750 
Chief Executive Officer and Director(3)  2024  $180,000(7)   100,000(8)   –(7)   –    –    –    24,786(9)   304,786 
Paul Chang,  2025  $246,552(11)   –    –    –    –    –    1,500(11)   248,052 
Former Chief Executive Officer (10)  2024  $420,000(12)   1,000,500(12, 13)   –    –    –    –    1,500(12)   1,422,000 
Janine Grasso,  2025  $34,029(14)   –    36,968(15)   –    –    –    –    70,997 
Former Interim Chief Executive Officer (14)  2024  $–    –    –    –    –    –    –    – 
Walid Khiari,  2025  $400,000(17)   –    –(19)   –    –    –    500(18)   400,500 
Chief Financial Officer and Chief Operating Officer(16)  2024  $50,000(20)   750(21)   –    53,657(22)   –    –    1,500(23)   333,650 
James D. Henderson, Jr.,  2025  $     –    –    –    –    –    180,000(25)(26)   180,000 
Corporate Secretary and General Counsel(24)  2024  $     –    –    –    –    –    180,000(25)(26)   180,000 
Venkata Ramana Pinnam  2025  $200,000(28)   –(29)   –    –    –    –    1,500(30)   201,500 
Director of Cybersecurity and Quality Assurance (27)  2024  $200,250 (31)   40,250 (29)   –    –    –    –    750(30)   241,250 

 

(1) The amounts reported in this column do not reflect the actual economic value realized by our named executive officers. In accordance with SEC rules, this column represents the aggregate grant date fair value of shares underlying stock awards, calculated based on the closing price of our Common Stock on the date of grant in accordance with ASC 718, with the exception that the amounts shown assume no forfeitures.

 

(2) The amounts reported under “Option Awards” are the estimated grant date fair value of stock options granted during the fiscal years ended December 31, 2024 and 2025, with such amount as determined under the ASC 718, Compensation - Stock Compensation (“ASC 718”), with respect to accounting for stock-based compensation expense. Such estimated fair value amounts do not necessarily correspond to the potential actual value realized of such awards. The assumptions made in computing the estimated fair value of such awards are disclosed in Note I of the Company’s audited consolidated financial statements included in the Original Filing.

 

12

 

 

(3) Mr. Luck served as President and Chief Product Officer until September 12, 2025, when he was appointed Chief Executive Officer, initially as Acting Chief Executive Officer. Mr. Luck also serves as a director and received no compensation for his service as a director.

 

(4) Represents base salary earned in 2025 at an annual rate of $180,000, consisting of $30,000 paid in cash in 2025, $75,000 paid in cash in 2026 and $75,000 that Mr. Luck elected to receive in shares of our Common Stock in lieu of cash salary for pay periods from February 1, 2025, through June 30, 2025. 15,546 shares of Common Stock were issued at $3.30 per share, the closing price on July 17, 2025, representing his net pay of $51,301.80.

 

(5) No stock options or stock awards were granted to Mr. Luck in 2025. The salary that Mr. Luck elected to receive in shares of Common Stock is reported in the Salary column. See footnote (4).

 

(6) Consists of $750 health insurance stipend.

 

(7) Includes $16,250 of 2024 salary that Mr. Luck elected to receive in shares of restricted stock. Mr. Luck received 625 shares of Common Stock on January 2, 2025, at a closing price of $10.70 and 792 shares on January 8, 2025, at a closing price of $7.80. These combined to equal Mr. Luck’s net pay of $12,865.10. This amount was reported in the Stock Awards column in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and is reported in the Salary column in accordance with SEC rules. Mr. Luck’s total 2024 compensation is unchanged.

 

(8) Consists of a $100,000 cash bonus earned in connection with the closing of the Business Combination.

 

(9) Consists of $24,786 received as a housing allowance.

 

(10) Mr. Chang was hired as Global President effective May 7, 2023, appointed Co-Chief Executive Officer on May 28, 2024, and appointed Chief Executive Officer effective August 22, 2024. The Board removed Mr. Chang as Chief Executive Officer on July 9, 2025. Mr. Chang continued to serve as a director until the annual meeting of stockholders held on November 26, 2025.

 

(11) Salary represents base salary earned in 2025 at an annual rate of $420,000 through July 10, 2025, of which $52,500 was paid in 2025 and the remainder of $194,052 was paid in 2026. This includes $105,000 of salary for the first quarter of 2025 that was deferred and as approved by the Board on June 16, 2025, was payable in six monthly installments of $17,500. All Other Compensation consists of $1,500 of health insurance stipend.

 

(12) 2024 Salary was paid at the annual rate of $420,000. In addition, Mr. Chang received a $250,000 cash bonus earned in connection with the closing of the Business Combination and $500 holiday bonus.

 

(13) Includes $750,000 of the Chang Merger Bonus that Mr. Chang elected to receive in 53,191 shares of Common Stock granted on May 13, 2024, at $14.10 per share, which is reported in the Bonus column rather than the Stock Awards column in accordance with SEC rules. 15,000 shares were withheld to satisfy the payroll tax obligation, resulting in Mr. Chang receiving 38,191 net shares.

 

(14) Ms. Grasso served as Interim Chief Executive Officer from July 15, 2025, until September 12, 2025, and as a non-employee director from February 2024 until her resignation from the Board on September 12, 2025. Represents compensation for service as Interim Chief Executive Officer earned in 2025 and paid in 2026.

 

(15) Represents compensation for service as a director, consisting of 3,454 shares of restricted stock granted January 2, 2025, under the 2024 Director Compensation Policy, based on the closing price of $10.70 per share. Ms. Grasso received no cash fees for her service as a director in 2025.

 

(16) Mr. Khiari was appointed Chief Financial Officer and Chief Operating Officer effective November 18, 2024. Mr. Khiari was not a named executive officer for 2024.

 

13

 

 

(17) Represents base salary earned in 2025 at an annual rate of $400,000 under Mr. Khiari’s offer letter dated November 7, 2024, including $233,333 earned in 2025 and paid in 2026 and $100,000 that Mr. Khiari elected to receive in shares of our Common Stock in lieu of cash salary for the February 15, 2025, through April 30, 2025, payroll periods, pursuant to an election made on June 30, 2025. 14,904 shares were issued August 5, 2025, at a closing price calculated based on prevailing market prices.

 

(18) Consists of $500 health insurance stipend paid in 2025.

 

(19) No stock awards were granted to Mr. Khiari in 2025. As described in footnote (17), Mr. Khiari elected to receive shares of Common Stock in lieu of accrued cash compensation during 2025, which is reported in the Salary column.

 

(20) Represents Mr. Khiari’s salary paid in 2024 as his employment began in November 2024.

 

(21) $750 was paid as a holiday bonus.

 

(22) Represents the grant date fair value of an option to purchase 60,000 shares of our Common Stock granted under Mr. Khiari’s offer letter as of his November 18, 2024 start date. The option vests in equal monthly installments over four years, subject to continued service.

 

(23) $1,500 was paid in 2024 as a health insurance stipend.

 

(24) Mr. Henderson has served as our Corporate Secretary and General Counsel since the closing of the Business Combination and served as Corporate Secretary and General Counsel of Prior BEN from April 2018. Mr. Henderson provides services to the Company as an independent contractor.

 

(25) Represents fees for services as an Independent Contractor serving as Corporate Secretary and General Counsel at an annual rate of $180,000, which Mr. Henderson agreed to receive in 41,666 and 6,818 shares of our Common Stock in lieu of cash, pursuant to Board consents dated May 2, 2025, and June 30, 2025. The 41,666 shares were issued under the 2024 LTIP at $3.60 per share, the closing price of the Common Stock on May 1, 2025. The 6,818 shares were also issued under the 2024 LTIP at $4.40 per share, the closing price of the Common Stock on June 30, 2025.

 

(26) Represents Mr. Henderson’s full contract amount for 2024 and 2025 (separately). Of these amounts, $22,500 was paid in cash for 2025 and $130,000 was paid in cash for 2024. The balances were converted to shares as described in footnote (25).

 

(27) Mr. Pinnam joined BEN in February 2021 as an advisor and has served as our Director of Cybersecurity and Quality Assurance since June 2026. Mr. Pinnam was not a named executive officer for 2024.

 

(28) Represents base salary earned in 2025 at an annual rate of $200,000 under Mr. Pinnam’s offer letter dated February 25, 2023, including $83,333 earned in 2025 and paid in 2026 and $83,333 that Mr. Pinnam elected to receive in shares of our Common Stock in lieu of cash salary. Mr. Pinnam received 946 shares on January 8, 2025, at the closing price of $7.80 per share and 18,776 shares on July 17, 2025, at the closing price of $3.30. The issuances represent his net pay of $7,378.80 and $61,960.80, respectively. Mr. Pinnam is eligible for an annual incentive bonus of up to $40,000, as determined by the Board; no bonus was awarded for 2025.

 

(29) No stock awards or options were granted to Mr. Pinnam in 2025. Mr. Pinnam received a cash bonus of $40,000 in 2024 in connection with the closing of the Business Combination. In addition, he received $250 holiday bonus.

 

(30) Consists of $1,500 health insurance stipend paid in 2025 and $750 in 2024.

 

(31) Mr. Pinnam received $200,250 in salary during 2024. $183,334 was paid in cash, while the balance was accrued and paid in 2025 as described in footnote (28).

 

14

 

 

Narrative Disclosure to Summary Compensation Table

 

Executive Employment Arrangements

 

We have entered into employment agreements with certain of our named executive officers that govern the terms of their continuing employment with us.

 

Agreements with Former Chief Executive Officer

 

On May 15, 2021, the Company entered into an advisory agreement with Mr. Paul Chang. On May 7, 2023, Mr. Chang became Global President and continued in this role through the Business Combination. On May 28, 2024, Mr. Chang was appointed as Co-Chief Executive Officer of the Company and effective August 22, 2024, Mr. Chang was appointed as Chief Executive Officer of the Company. On July 9, 2025, the Board removed Mr. Chang as Chief Executive Officer. In June 2025, the Board approved paying Mr. Chang’s deferred first-quarter 2025 salary of $105,000 in six monthly installments of $17,500.

 

The Company entered into an employment agreement with Mr. Chang, effective May 7, 2023, and pursuant to its terms, Mr. Chang’s base salary was $420,000. The term of Mr. Chang’s employment agreement was three years, unless terminated earlier. Mr. Chang was eligible to receive an annual incentive bonus with a target equal to 50% of his year-end base salary for year one and the opportunity to earn a bonus equal to up to 100% of his then current base salary in each subsequent year, with the precise amount to be determined by the Board. Mr. Chang’s employment agreement entitled Mr. Chang to participate in any bonus compensation plans that the Company may from time to time adopt for the benefit of management, along with any standard benefit plans available to similarly situated employees. Each year, Mr. Chang was entitled to 30 days of paid time off, in addition to sick leave and regular holidays. If not used each year, or at the time his employment ends for any reason, Mr. Chang is entitled to payment for all unused vacation time. If Mr. Chang’s employment was terminated by the Company without good cause or by Mr. Chang with good reason, he is entitled to receive his base salary through the end of the term of his employment agreement or his base salary for one year, whichever is greater, along with any unpaid vested options, equity or earned bonuses.

 

Mr. Chang entered into a post-merger employment agreement, which became effective upon the closing of the Business Combination, and governs the terms of Mr. Chang’s employment following the closing of the Business Combination. Terms related to compensation under the post-merger employment agreement are substantially similar to those under his prior employment agreement with the Company, except that any stock options granted under this post-merger employment agreement are options to purchase shares of Common Stock rather than Prior BEN Common Stock and is subject to the terms of the 2024 LTIP. In addition, Mr. Chang was entitled to receive a cash bonus with a value of $1,000,000 in cash, stock or a combination of both cash and stock, in the Company’s discretion, upon the closing of the Business Combination, provided the value of the Company at such time exceeded $100,000,000 (the “Chang Merger Bonus”).

 

On April 22, 2024, Mr. Chang entered into an amendment to his post-merger employment agreement (the “Chang Amendment”) that provided for the payment of the Chang Merger Bonus in the form of (i) a cash payment equal to $250,000.00, and (ii) a fully vested award of 53,191 shares of restricted stock granted on May 13, 2024, and subject to the terms and conditions of the 2024 LTIP and the Company’s form of restricted stock grant agreement. Share number was adjusted for the reverse stock split.

 

The obligations under the Chang Amendment were fully satisfied in the first quarter of 2026.

 

15

 

 

Agreements with Chief Executive Officer

 

The Company entered into an employment agreement with Mr. Luck, effective May 31, 2023, when Mr. Luck was hired as Chief Product Officer that continues to govern his employment as Chief Executive Officer and pursuant to its terms, Mr. Luck’s base salary is $180,000. The term of Mr. Luck’s employment agreement is three years, unless terminated upon the earlier of the closing of the Business Combination or June 1, 2026. Mr. Luck is eligible to receive a discretionary cash bonus in an amount to be determined by the Board or the Compensation Committee thereunder. Mr. Luck’s employment agreement entitles Mr. Luck to participate in any bonus compensation plans that the Company may from time to time adopt for the benefit of management, along with any standard benefit plans available to similarly situated employees. Each year, Mr. Luck is entitled to 30 days of paid time off, in addition to sick leave and regular holidays. If not used each year, or at the time his employment ends for any reason, Mr. Luck is entitled to payment for all unused vacation time. If Mr. Luck’s employment is terminated by the Company without good cause or by Mr. Luck with good reason, he is entitled to receive his base salary through the end of the term of his employment agreement or his base salary for one year, whichever is greater, along with any unpaid vested options, equity or earned bonuses.

 

Mr. Luck entered into a post-merger employment agreement, which became effective upon the closing of the Business Combination, and governs the terms of Mr. Luck’s employment as President and Chief Product Officer and, since September 12, 2025, Chief Executive Officer of the Company following the closing of the Business Combination. Terms related to compensation under the post-merger employment agreement are substantially similar to those under his prior employment agreement with the Company, except that any stock options granted under this post-merger employment agreement are options to purchase shares of Common Stock rather than Prior BEN Common Stock and is subject to the terms of the 2024 LTIP. In addition, Mr. Luck received a bonus of $100,000 upon the consummation of the Business Combination.

 

Mr. Luck’s appointment as Chief Executive Officer did not result in any material change to his compensation. During 2025, Mr. Luck elected to receive a portion of his salary for pay periods from February 1, 2025 through June 30, 2025 in shares of our Common Stock in lieu of cash, based on the closing price of our Common Stock on each payroll date, as approved by the Board on June 30, 2025.

 

Agreements with Chief Financial Officer – Walid Khiari

 

On November 7, 2024, the Company entered into an offer letter with Mr. Khiari providing for his employment as Chief Financial Officer and Chief Operating Officer beginning November 18, 2024. Under the offer letter, Mr. Khiari receives an annual base salary of $400,000 and is eligible to earn an annual performance bonus of up to 100% of his base salary, based 50% on corporate and 50% on individual performance objectives established by the Compensation Committee during the first quarter of each fiscal year and payable no later than March 15 of the following year. Beginning with fiscal 2026, Mr. Khiari is entitled to an annual equity award on terms no less favorable than annual awards to our other non-CEO senior executive officers and with a value no less than the median value of annual equity awards to chief financial officers of a peer group established by the Compensation Committee. The offer letter provided for an option to purchase 60,000 shares of our Common Stock (600,000 shares prior to the reverse stock split), to be granted on his start date with an exercise price equal to the fair market value of the Common Stock on that date, vesting in equal monthly installments over four years and subject to the 2024 LTIP. The Board approved the option by written consent dated February 25, 2025. Mr. Khiari is entitled to 30 days of paid time off per year. Unless his employment is terminated for cause or he resigns, Mr. Khiari is entitled to severance equal to 90 days of salary, subject to the BEN Severance Plan, and, if his employment is terminated without good cause or he resigns for good reason during the period beginning three months before and ending 12 months after a change in control, all of his then-unvested equity awards will vest in full. In 2025, Mr. Khiari elected to receive his after-tax salary for the February 15, 2025 through April 30, 2025 payroll periods in shares of our Common Stock in lieu of cash.

 

Arrangements with Former Interim Chief Executive Officer – Janine Grasso

 

On July 9, 2025, the Board appointed Ms. Grasso, then a member of the Board, as Interim Chief Executive Officer. Though the Company and Ms. Grasso never entered into a formal employment agreement, the Company and Ms. Grasso entered into a “Success Fee Agreement” following her departure as Interim CEO. Pursuant to that agreement, the Company has agreed to pay Ms. Grasso $250,000 from any monetary recovery the Company may receive via litigation prior to January 1, 2027. If there is no monetary recovery by the Company as of that date, Ms. Grasso has the option to receive the $250,000 success fee in the form of the Company’s common stock.

 

16

 

 

Arrangements with Corporate Secretary and General Counsel – James D. Henderson, Jr.

 

Mr. Henderson provides services as Corporate Secretary and General Counsel as an independent contractor under an agreement dated May 1, 2023. On May 2, 2025 and June 30, 2025, the Board approved the conversion of $150,000 and $30,000, respectively, of fees owed to Mr. Henderson for services into shares of our Common Stock.

 

Agreements with Director of Cybersecurity and Quality Assurance – Venkata Ramana Pinnam

 

On February 25, 2023, Prior BEN entered into an offer letter with Mr. Pinnam, which he accepted on March 1, 2023, providing for his employment as Senior Vice President of Engineering. Under the offer letter, Mr. Pinnam receives an annual base salary of $200,000 and is eligible to earn an annual incentive bonus of up to $40,000, as determined by the Board. The offer letter provides that, subject to a separate equity incentive plan, Mr. Pinnam will accrue options to purchase 10,000 shares of Prior BEN Common Stock per year for three years. Mr. Pinnam is entitled to 30 days of paid time off per year. Unless his employment is terminated for cause or he resigns, the Company will pay Mr. Pinnam the remainder of his salary for the three-year term of his employment. Mr. Pinnam has served as our Director of Cybersecurity and Quality Assurance since January 1, 2026. During 2025, Mr. Pinnam elected to receive a portion of his salary in shares of our Common Stock in lieu of cash, as approved by the Board on June 30, 2025.

 

Outstanding Equity Awards At 2025 Fiscal Year End

 

The following table lists the outstanding equity awards held by the named executive officers as of December 31, 2025.

 

Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Option Exercise Price ($)   Option Expiration Date   Number of Shares or Units of Stock That Have Not Vested (#)   Market Value of Shares or Units of Stock That Have Not Vested ($) 
Tyler Luck   –    –    –   –    –    – 
Paul Chang   –    –    –   –    –    – 
Janine Grasso   –    –    –   –    –    – 
Walid Khiari   16,250(1)   43,750(1)   8.10   November 18, 2028    –    – 
James D. Henderson, Jr.   –    –    –   –    –    – 
Venkata Ramana Pinnam   –    –    –   –    –    – 

 

(1) Represents an option to purchase 60,000 shares of Common Stock, with an exercise price of $8.10 per share, granted as of Mr. Khiari’s November 18, 2024 start date and approved by the Board by unanimous written consent effective February 25, 2025. The option vests in equal monthly installments over four years beginning November 18, 2024, subject to continued service. 16,250 shares had vested as of December 31, 2025.

 

Equity Compensation Plan Information

 

2021 Equity Incentive Plan

 

In 2021, the board of directors of Prior BEN adopted, and Prior BEN’s stockholders approved, the 2021 Equity Incentive Plan. The following describes the material terms of the 2021 Equity Incentive Plan. In connection with the Closing of the Business Combination, the 2021 Equity Incentive Plan and all outstanding awards under the 2021 Equity Incentive Plan were assumed by the Company, and the 2021 Equity Incentive Plan was terminated with respect to future awards. Forfeitures of awards under the 2021 Equity Incentive Plan are automatically added to the pool of shares available for issuance under the 2024 LTIP. Upon Closing, each Stock Award (as defined below) was adjusted in accordance with the Exchange Ratio (as defined herein).

 

17

 

 

Grants, Generally. The 2021 Equity Incentive Plan provides both for the direct award or sale of shares and the grant of incentive stock options (“ISOs”), non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards and other stock awards (together, the “Stock Awards”). Employees, directors and consultants of the Company are eligible to receive Stock Awards.

 

The maximum number of shares of Common Stock that could have been issued over the term of the 2021 Equity Incentive Plan is 270,100 shares. As of December 31, 2025, stock options to purchase 138,640 shares of Common Stock with a weighted-average exercise price of $4.90 per share were outstanding under the 2021 Equity Incentive Plan. As of December 31, 2025, there were no outstanding awards under the 2021 Equity Incentive Plan, other than these options.

 

Administration. The Board, or a committee with authority delegated by the Board, administers the 2021 Equity Incentive Plan. Subject to the terms of the 2021 Equity Incentive Plan, the administrator has the power to determine: who will be granted Stock Awards; when and how each Stock Award will be granted; what type of Stock Award will be granted; the provisions of each Stock Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Stock Award; the number of shares of Common Stock subject to a Stock Award; and the fair market value applicable to a Stock Award. The administrator also has the authority to accelerate the time(s) at which an award may vest or be exercised, and to construe, interpret, and settle all controversies regarding the terms of the 2021 Equity Incentive Plan and awards granted thereunder.

 

Options. The Company’s employees, directors and consultants (although incentive stock options may be granted only to employees) are eligible to receive stock options pursuant to the 2021 Equity Incentive Plan. See the “Outstanding Equity Awards at 2025 Fiscal Year End” table below for further information about the Company’s named executive officer’s outstanding options as of December 31, 2025.

 

The exercise price per share of options granted under the 2021 Equity Incentive Plan must be at least 100% of the fair market value per share of Common Stock on the grant date (110% for incentive stock options granted to holders of more than 10% of the total combined voting power of the Company’s stock), except that options granted in assumption of or substitution for other options in a corporate transaction may have a lower exercise price. Options may not be exercisable more than ten years after the grant date (five years for incentive stock options granted to such 10% holders). Subject to the provisions of the 2021 Equity Incentive Plan, the administrator determines the other terms of options, including any vesting and exercisability requirements, the method of payment of the option exercise price, and the option expiration date, among other determinations.

 

Changes to Capital Structure; Corporate Transactions. In the event of certain changes to the Company’s capital structure, such as a stock split, reverse stock split, stock dividend, combination, recapitalization or reclassification of the Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration, appropriate adjustments will be made to (i) the class(es) and maximum number of securities subject to the 2021 Equity Incentive Plan, (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of ISOs, and (iii) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. In the event the Company is party to a “Corporate Transaction” or “Change in Control” (as each is defined in the 2021 Equity Incentive Plan), the Board may, unless otherwise provided in the applicable award agreement, in another written agreement with the participant, or by the Board at the time of grant, take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the transaction in question:

 

(i) arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the transaction);

 

18

 

 

(ii) arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company);

 

(iii) accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five (5) days prior to the effective date of the transaction), with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the transaction; provided, however, that the Board may require participants under the 2021 Equity Incentive Plan to complete and deliver to the Company a notice of exercise before the effective date of a transaction, which exercise is contingent upon the effectiveness of such transaction;

 

(iv) arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award;

 

(v) cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and

 

(vi) make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the participant to the 2021 Equity Incentive Plan would have received upon the exercise of the Stock Award immediately prior to the effective time of the transaction, over (B) any exercise price payable by such holder in connection with such exercise. For clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments may be delayed to the same extent that payment of consideration to the holders of Common Stock in connection with the transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies. The Board need not take the same action with respect to all Stock Awards or all participants. Acceleration of vesting or exercisability in connection with a Change in Control will occur only if provided for in the applicable award agreement or another written agreement between the participant and the Company or an affiliate.

 

Plan Amendment or Termination. The Board may amend, modify, or terminate the 2021 Equity Incentive Plan at any time, although such change may not materially and adversely affect a participant’s rights under an outstanding award without the participant’s written consent, except in limited circumstances (for example, to preserve incentive stock option status, to comply with Section 409A of the Internal Revenue Code or other applicable law, or where the Board determines that the change does not materially impair the participant’s rights). The Company is also required to seek stockholder approval of certain material amendments to the extent required by applicable law.

 

2024 LTIP

 

Summary and Purpose. On the Closing Date, Brand Engagement Network Inc. 2024 Long-Term Incentive Plan (the “2024 LTIP”) became effective (the “Effective Date”). The 2024 LTIP was approved by DHC’s stockholders at the Special Meeting. The purpose of the 2024 LTIP is to attract and retain the services of key employees, key contractors, and non-employee directors of the Company and its subsidiaries and to provide such persons with a proprietary interest in the Company through the granting of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, performance goals, tandem awards, prior plan awards, and other awards, whether granted singly, or in combination, or in tandem, that will (i) increase the interest of such persons in the Company’s welfare, (ii) furnish an incentive to such persons to continue their services for the Company or its subsidiaries, and (iii) provide a means through which the Company may attract and retain able persons as employees, contractors, and non-employee directors. Employees, officers, contractors, any non-employee director of the Board are eligible to receive awards under the 2024 LTIP. The 2024 LTIP is administered by the Board or its designees, referred to herein as the “plan administrator”. The plan administrator has the authority to take all actions and make all determinations under the 2024 LTIP, to interpret the 2024 LTIP and award agreements and to adopt, amend and repeal rules for the administration of the 2024 LTIP as it deems advisable. The plan administrator also has the authority to grant awards, to determine which eligible service providers receive awards, and to set the terms and conditions of all awards under the 2024 LTIP, including any vesting and vesting acceleration provisions, subject to the conditions and limitations in the 2024 LTIP.

 

19

 

 

Share Authorization. Subject to certain adjustments and any increase by any Prior Plan Awards (as defined below) eligible for reuse as described below, the aggregate number of shares of our Common Stock issuable under the 2024 LTIP in respect of awards is equal to 5% of the aggregate number of shares issued and outstanding (or issuable upon the conversion or exchange of outstanding securities of the Company or its subsidiaries) determined as of the Effective Date, which as of such date was 275,930 shares of Common Stock, of which 100% of the available shares may be delivered pursuant to incentive stock options (the “ISO Limit”). Notwithstanding the foregoing, subject to approval by the Board, on the first trading date of each calendar year (the “Adjustment Date”), the number of shares of our Common Stock available under the 2024 LTIP may be increased by up to an additional 5% of the total number of shares issued and outstanding, as determined as of the Adjustment Date, provided, however, in no event shall the authorized shares available for awards under the 2024 Plan ever exceed 15% of the total number of shares of our Common Stock issued and outstanding, determined as of the Effective Date, provided, further, however, that no such adjustment shall have any effect on, or otherwise change the ISO Limit, except for any adjustments summarized below. Shares to be issued may be made available from authorized but unissued Common Stock, Common Stock held by the Company in its treasury, or Common Stock purchased by the Company on the open market or otherwise. During the term of the 2024 LTIP, the Company will at all times reserve and keep enough Common Stock available to satisfy the requirements of the 2024 LTIP.

 

The term “Prior Plan Awards” means (a) any awards under the 2021 Equity Incentive Plan that are outstanding on the Effective Date, and that on or after the Effective Date, are forfeited, expire or are canceled; and (b) any shares subject to awards relating to Common Stock under the 2021 Equity Incentive Plan that, on or after the Effective Date are settled in cash.

 

Reuse of Shares. To the extent that any award under the 2024 LTIP or any Prior Plan Award is cancelled, forfeited or expires, in whole or in part, the shares subject to such forfeited, expired or cancelled award may again be awarded under the 2024 LTIP. Awards that may be satisfied either by the issuance of Common Stock or by cash or other consideration shall be counted against the maximum number of shares of Common Stock that may be issued under the 2024 LTIP only during the period that the award is outstanding or to the extent the award is ultimately satisfied by the issuance of Common Stock. If previously acquired shares of Common Stock are delivered to the Company in payment of the exercise price of a stock option, the number of shares available for future awards will be reduced only by the net number of shares issued upon exercise. Awards will not reduce the number of shares of Common Stock that may be issued, however, if the settlement of the award will not require the issuance of Common Stock. Only shares forfeited back to the Company, shares cancelled on account of termination, expiration or lapse of an award, shares surrendered in payment of the exercise price of a stock option, or shares withheld for payment of applicable taxes, shall again be available for grant of incentive stock options under the 2024 LTIP, but shall not increase the maximum number of shares described above as the maximum number of shares of Common Stock that may be delivered pursuant to incentive stock options.

 

Administration. Subject to the terms of the 2024 LTIP, the 2024 LTIP shall be administered by the Board, or such committee of the Board as is designated by the Board to administer the Plan (the “Committee”). Membership on the Committee shall be limited to “non-employee directors” in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended. The Committee may delegate certain duties to one or more officers of the Company as provided in the 2024 LTIP. The Committee will determine the persons to whom awards are to be made in accordance with applicable law, determine the type, size and terms of awards in accordance with applicable law, interpret the 2024 LTIP, establish and revise rules and regulations relating to the 2024 LTIP, settle all controversies regarding the 2024 LTIP and awards, accelerate the vesting of awards, approve forms of award agreements, and make any other determinations that it believes necessary for the administration of the 2024 LTIP.

 

Eligibility. Employees (including any employee who is also a director or an officer), contractors, and non-employee directors of the Company or its subsidiaries whose judgment, initiative and efforts contributed to or may be expected to contribute to the successful performance of the Company are eligible to participate in the 2024 LTIP. As of April 14, 2026, the Company (including its subsidiaries) had approximately 26 full-time employees and nine independent contractors. The Committee shall, in its sole discretion, select the employees, contractors, and non-employee directors who will participate in the 2024 LTIP in order to attract, reward and retain top performers and key management.

 

20

 

 

Financial Effect of Awards. The Company will receive no monetary consideration for the granting of awards under the 2024 LTIP, unless otherwise provided when granting restricted stock or restricted stock units. The Company will receive no monetary consideration other than the option price for Common Stock issued to participants upon the exercise of their stock options, and the Company will receive no monetary consideration upon the exercise of stock appreciation rights.

 

Stock Options. The Committee may grant either incentive stock options qualifying under Section 422 of the Internal Revenue Code, as amended (the “Code”) or non-qualified stock options, provided, that only employees of the Company and its subsidiaries (excluding subsidiaries that are not corporations) are eligible to receive incentive stock options. Stock options may not be granted with an option price less than 100% of the fair market value of a common share on the date the stock option is granted. If an incentive stock option is granted to an employee who owns or is deemed to own more than 10% of the combined voting power of all classes of stock of the Company (or any parent or subsidiary), the option price shall be at least 110% of the fair market value of a common share on the date of grant. The Committee will determine the terms of each stock option at the time of grant, including without limitation, the methods by or forms in which shares will be delivered to participants. The maximum term of each option, the times at which each option will be exercisable, and provisions requiring forfeiture of unexercised options at or following termination of employment or service generally are fixed by the Committee, except that the Committee may not grant stock options with a term exceeding 10 years or, in the case of an incentive stock option granted to an employee who owns or is deemed to own more than 10% of the combined voting power of all classes of Common Stock (or of any parent or subsidiary), five years.

 

Recipients of stock options may pay the option exercise price (i) in cash, check, bank draft or money order payable to the order of the Company, (ii) by delivering to Common Stock (including restricted stock) already owned by the participant having a fair market value equal to the aggregate option exercise price, provided, that the participant has not acquired such stock within six months prior to the date of exercise, (iii) by delivering to the Company or its designated agent an executed irrevocable option exercise form together with irrevocable instructions from the participant to a broker or dealer, reasonably acceptable to the Company, to sell certain of the Common Stock purchased upon the exercise of the option or to pledge such shares to the broker as collateral for a loan from the broker and to deliver to the Company the amount of sale or loan proceeds necessary to pay the purchase price, (iv) by requesting the Company to withhold the number of shares otherwise deliverable upon exercise of the stock option by the number of shares of Common Stock having an aggregate fair market value equal to the aggregate exercise price at the time of exercise (i.e., a cashless net exercise), and (v) by any other form of valid consideration that is acceptable to the Committee in its sole discretion.

 

Stock Appreciation Rights. The Committee is authorized to grant stock appreciation rights (“SARs”) as a stand-alone award (or freestanding SARs), or in conjunction with stock options granted under the 2024 LTIP (or tandem SARs). A SAR is the right to receive an amount equal to the excess of the fair market value of a common share on the date of exercise over the exercise price. The exercise price may be equal to or greater than the fair market value of a common share on the date of grant. The Committee, in its sole discretion, may place a ceiling on the amount payable on the exercise of a SAR, but any such limitation shall be specified at the time the SAR is granted. A SAR granted in tandem with a stock option will require the holder, upon exercise, to surrender the related stock option with respect to the number of shares as to which the SAR is exercised. The Committee will determine the terms of each SAR at the time of the grant, including without limitation, the methods by or forms in which the value will be delivered to participants (whether made in Common Stock, in cash or in a combination of both). The maximum term of each SAR, the times at which each SAR will be exercisable, and provisions requiring forfeiture of unexercised SARs at or following termination of employment or service generally are fixed by the Committee, except that no freestanding SAR may have a term exceeding 10 years and no tandem SAR may have a term exceeding the term of the option granted in conjunction with the tandem SAR.

 

Restricted Stock and Restricted Stock Units. The Committee is authorized to grant restricted stock and restricted stock units. Restricted stock consists of shares that are transferred or sold by the Company to a participant but are subject to substantial risk of forfeiture and to restrictions on their sale or other transfer by the participant. Restricted stock units are the right to receive Common Stock at a future date in accordance with the terms of such grant upon the attainment of certain conditions specified by the Committee, which include substantial risk of forfeiture and restrictions on their sale or other transfer by the participant. The Committee determines the eligible participants to whom, and the time or times at which, grants of restricted stock or restricted stock units will be made, the number of shares or units to be granted, the price to be paid, if any, the time or times within which the shares covered by such grants will be subject to forfeiture, the time or times at which the restrictions will terminate, and all other terms and conditions of the grants. Restrictions or conditions could include, but are not limited to, the attainment of performance goals (as described below), continuous service with the Company, the passage of time or other restrictions or conditions.

 

21

 

 

Performance Awards. The Committee may grant performance awards payable in cash, Common Stock, or a combination thereof at the end of a specified performance period. Payment will be contingent upon achieving pre-established performance goals (as described below) by the end of the performance period. The Committee will determine the length of the performance period, the maximum payment value of an award, and the minimum performance goals required before payment will be made, so long as such provisions are not inconsistent with the terms of the 2024 LTIP, and to the extent an award is subject to Section 409A of the Code, are in compliance with the applicable requirements of Section 409A of the Code and any applicable regulations or guidance. With respect to a performance award, if the Committee determines in its sole discretion that the established performance measures or objectives are no longer suitable because of a change in the Company’s business, operations, corporate structure, or for other reasons that the Committee deems satisfactory, the Committee may modify the performance measures or objectives and/or the performance period.

 

Dividend Equivalent Rights. The Committee may grant a dividend equivalent right either as a component of another award or as a separate award, provided, that dividend equivalent rights may not be granted as a component of SARs or stock options. The terms and conditions of the dividend equivalent right shall be specified by the grant. Dividend equivalents credited to the holder of a dividend equivalent right may be paid currently or may be deemed to be reinvested in additional Common Stock. Any such reinvestment shall be at the fair market value at the time thereof. Dividend equivalent rights may be settled in cash or Common Stock.

 

Other Awards. The Committee may grant other forms of awards payable in cash or Common Stock if the Committee determines that such other form of award is consistent with the purpose and restrictions of the 2024 LTIP. The terms and conditions of such other form of award shall be specified by the grant. Such other awards may be granted for no cash consideration, for such minimum consideration as may be required by applicable law, or for such other consideration as may be specified by the grant.

 

Performance Goals. Awards (whether relating to cash or Common Stock) under the 2024 LTIP may be made subject to the attainment of performance goals relating to one or more business criteria, and may consist of one or more or any combination of the following criteria: cash flow; cost; revenues; sales; ratio of debt to debt plus equity; net borrowing, credit quality or debt ratings; profit before tax; economic profit; earnings before interest and taxes; earnings before interest, taxes, depreciation and amortization; gross margin; earnings per share (whether on a pre-tax, after-tax, operational or other basis); operating earnings; capital expenditures; expenses or expense levels; economic value added; ratio of operating earnings to capital spending or any other operating ratios; free cash flow; net profit; net sales; net asset value per share; the accomplishment of mergers, acquisitions, dispositions, public offerings or similar extraordinary business transactions; sales growth; price of the Company’s Common Stock; return on assets, equity or stockholders’ equity; market share; inventory levels, inventory turn or shrinkage; total return to stockholders; or any other criteria determined by the Committee (“Performance Criteria”). Any Performance Criteria may be used to measure the performance of the Company as a whole or any business unit of the Company and may be measured relative to a peer group or index. Any Performance Criteria may include or exclude (i) events that are of an unusual nature or indicate infrequency of occurrence, (ii) gains or losses on the disposition of a business, (iii) changes in tax or accounting regulations or laws, (iv) the effect of a merger or acquisition, as identified in the Company’s quarterly and annual earnings releases, or (v) other similar occurrences. In all other respects, Performance Criteria shall be calculated in accordance with the Company’s financial statements, under generally accepted accounting principles, or under a methodology established by the Committee prior to the issuance of an award which is consistently applied and identified in the audited financial statements, including footnotes, or the Compensation Discussion and Analysis section of the Company’s annual report.

 

Vesting of Awards; Forfeiture; Assignment. The Committee, in its sole discretion, may establish the vesting terms applicable to an award, subject in any case to the terms of the 2024 LTIP. The Committee may impose on any award, at the time of grant or thereafter, such additional terms and conditions as the Committee determines, including terms requiring forfeiture of awards in the event of a participant’s termination of service. The Committee will specify the circumstances under which performance awards may be forfeited in the event of a participant’s termination of service by a participant prior to the end of a performance period or settlement of awards. Except as otherwise established by the Committee in the award agreement setting forth the terms, restricted stock will be forfeited upon a participant’s termination of service during the applicable restriction period.

 

22

 

 

Assignability. Awards granted under the 2024 LTIP generally are not assignable or transferable except by will or by the laws of descent and distribution, except that the Committee may, in its discretion and pursuant to the terms of an award agreement, permit certain transfers of awards to: (i) the spouse (or former spouse), children or grandchildren of the participant (“Immediate Family Members”); (ii) a trust or trusts for the exclusive benefit of such Immediate Family Members; (iii) a partnership in which the only partners are (1) such Immediate Family Members and/or (2) entities which are controlled by the participant and/or Immediate Family Members; (iv) an entity exempt from federal income tax pursuant to Section 501(c)(3) of the Code or any successor provision; or (v) a split interest trust or pooled income fund described in Section 2522(c)(2) of the Code or any successor provision, provided, that (x) there shall be no consideration for any such transfer, (y) the applicable award agreement pursuant to which such award is granted must be approved by the Committee and must expressly provide for such transferability and (z) subsequent transfers of transferred awards shall be prohibited except those by will or the laws of descent and distribution.

 

Adjustments Upon Changes in Capitalization. In the event that any dividend or other distribution, recapitalization, stock split, reverse stock split, rights offering, reorganization, merger, consolidation, split-up, spin-off, split-off, combination, subdivision, repurchase, or exchange of the Common Stock or other securities of the Company, issuance of warrants or other rights to purchase Common Stock or other securities of the Company, or other similar corporate transaction or event affects the fair value of an award, then the Committee shall adjust any or all of the following so that the fair value of the award immediately after the transaction or event is equal to the fair value of the award immediately prior to the transaction or event (i) the number of shares and type of Common Stock (or the securities or property) which thereafter may be made the subject of awards, (ii) the number of shares and type of Common Stock (or other securities or property) subject to outstanding awards, (iii) the option price of each outstanding award, (iv) the amount, if any, the Company pays for forfeited Common Stock in accordance with the terms of the 2024 LTIP, and (v) the number of or exercise price of Common Stock then subject to outstanding SARs previously granted and unexercised under the 2024 LTIP to the end that the same proportion of the Company’s issued and outstanding Common Stock in each instance shall remain subject to exercise at the same aggregate exercise price; provided, however, that the number of Common Stock (or other securities or property) subject to any award shall always be a whole number. Notwithstanding the foregoing, no such adjustment shall be made or authorized to the extent that such adjustment would cause the 2024 LTIP or any stock option to violate Section 422 of the Code or Section 409A of the Code. All such adjustments must be made in accordance with the rules of any securities exchange, stock market, or stock quotation system to which the Company is subject.

 

Treatment of Awards in a Change in Control. Unless otherwise provided in the applicable award agreement, in any other written agreement between the participant and the Company or any subsidiary, or by the Board at the time of grant, in the event of a Change in Control (as described below) the Board may, contingent upon the closing or completion of the Change in Control, take one or more of the following actions with respect to awards: (i) arrange for the surviving or acquiring corporation (or its parent company) to assume or continue the award or substitute a similar award; (ii) arrange for the assignment of any reacquisition or repurchase rights held by the Company to the surviving or acquiring corporation (or its parent company); (iii) accelerate the vesting, in whole or in part, of the award (and, if applicable, the time at which it may be exercised) to a date prior to the effective time of the Change in Control determined by the Board (or, if the Board does not determine a date, five days prior to the effective date), with the award terminating if not exercised at or prior to the effective time, provided that the Board may require participants to deliver a notice of exercise before the effective date that is contingent upon the effectiveness of the Change in Control; (iv) arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights; (v) cancel the award, to the extent not vested or exercised prior to the effective time, in exchange for such cash consideration (including no consideration) as the Board, in its sole discretion, considers appropriate; and (vi) make a payment equal to the excess, if any, of the value of the property the participant would have received upon exercise immediately prior to the effective time over any exercise price payable (which payment may be zero if that value is equal to or less than the exercise price, and which may be delayed to the same extent that payment to holders of Common Stock is delayed as a result of escrows, earn outs, holdbacks or other contingencies). The Board need not take the same action with respect to all awards or all participants and may take different actions with respect to the vested and unvested portions of an award. An award that by its terms would be fully vested or exercisable upon a Change in Control will be considered vested or exercisable for purposes of clause (i). For purposes of the 2024 LTIP, a “Change in Control” generally means (a) any person becoming the beneficial owner of more than 50% of the combined voting power of the Company’s then outstanding securities (excluding securities acquired directly from the Company or its affiliates); (b) the individuals who constitute the Board on the Effective Date, together with new directors approved or recommended by at least two-thirds of the directors then in office who were directors on the Effective Date or were previously so approved, ceasing to constitute a majority of the Board; (c) the consummation of a merger or consolidation of the Company or any subsidiary with another corporation, other than a merger or consolidation after which the Company’s voting securities outstanding immediately prior continue to represent at least 50% of the combined voting power of the surviving entity (or its parent), or that is effected to implement a recapitalization in which no person becomes the beneficial owner of 50% or more of the Company’s combined voting power; or (d) stockholder approval of a plan of complete liquidation or dissolution of the Company, or the consummation of a sale or disposition of all or substantially all of the Company’s assets, other than to an entity at least 50% of the voting power of which is owned by the Company’s stockholders in substantially the same proportions. For any award subject to Section 409A of the Code, an event will constitute a Change in Control only if it also constitutes a change in ownership, effective control or ownership of a substantial portion of assets within the meaning of Section 409A of the Code.

 

23

 

 

Amendment or Discontinuance of the 2024 LTIP. The Board may, at any time and from time to time, without the consent of the participants, alter, amend, revise, suspend or discontinue the 2024 LTIP in whole or in part; provided, however, that (i) no amendment that requires stockholder approval in order for the 2024 LTIP and any awards under the 2024 LTIP to continue to comply with Sections 421 and 422 of the Code (including any successors to such Sections, or other applicable law) or any applicable requirements of any securities exchange or inter-dealer quotation system on which the Company’s stock is listed or traded, shall be effective unless such amendment is approved by the requisite vote of the Company’s stockholders entitled to vote on the amendment; and (ii) unless required by law, no action by the Board regarding amendment or discontinuance of the 2024 LTIP may adversely affect any rights of any participants or obligations of the Company to any participants with respect to any outstanding award under the 2024 LTIP without the consent of the affected participant. The 2024 LTIP will terminate on the tenth anniversary of the Effective Date unless sooner terminated by the Board, but awards granted before that date will continue in accordance with their terms.

 

No Repricing of Stock Options or SARs. The Committee may not, without the approval of the Company’s stockholders, “reprice” any stock option or SAR. For purposes of the 2024 LTIP, “reprice” means any of the following or any other action that has the same effect: (i) amending a stock option or SAR to reduce its exercise price or base price, (ii) canceling a stock option or SAR at a time when its exercise price or base price exceeds the fair market value of a common share in exchange for cash or a stock option, SAR, award of restricted stock or other equity award, or (iii) taking any other action that is treated as a repricing under generally accepted accounting principles, provided, that nothing shall prevent the Committee from (x) making adjustments to awards upon changes in capitalization; (y) exchanging or cancelling awards upon a merger, consolidation, or recapitalization, or (z) substituting awards for awards granted by other entities, to the extent permitted by the 2024 LTIP.

 

Recoupment for Restatements. The Committee may recoup all or any portion of any shares or cash paid to a participant in connection with an award, in the event of a restatement of the Company’s financial statements as set forth in the Company’s clawback policy, if any, approved by the Board from time to time.

 

Federal Income Tax Consequences. The following is a brief summary of certain federal income tax consequences relating to the transactions described under the 2024 LTIP as set forth below. This summary does not purport to address all aspects of federal income taxation and does not describe state, local or foreign tax consequences. This discussion is based upon provisions of the Code and the treasury regulations issued thereunder, and judicial and administrative interpretations under the Code and treasury regulations, all as in effect as of April 13, 2026, and all of which are subject to change (possibly on a retroactive basis) or different interpretation.

 

Law Affecting Deferred Compensation. In 2004, Section 409A was added to the Code to regulate all types of deferred compensation. If the requirements of Section 409A of the Code are not satisfied, deferred compensation and earnings thereon will be subject to tax as it vests, plus an interest charge at the underpayment rate plus 1% and a 20% penalty tax. Certain performance awards, stock options, stock appreciation rights, restricted stock units and certain types of restricted stock are subject to Section 409A of the Code.

 

24

 

 

Incentive Stock Options. A participant will not recognize income at the time an incentive stock option is granted. When a participant exercises an incentive stock option, a participant also generally will not be required to recognize income (either as ordinary income or capital gain). However, to the extent that the fair market value (determined as of the date of grant) of the Common Stock with respect to which the participant’s incentive stock options are exercisable for the first time during any year exceeds $100,000, the incentive stock options for the Common Stock over $100,000 will be treated as non-qualified stock options, and not incentive stock options, for federal tax purposes, and the participant will recognize income as if the incentive stock options were non-qualified stock options. In addition to the foregoing, if the fair market value of the Common Stock received upon exercise of an incentive stock option exceeds the exercise price, then the excess may be deemed a tax preference adjustment for purposes of the federal alternative minimum tax calculation. The federal alternative minimum tax may produce significant tax repercussions depending upon the participant’s particular tax status.

 

The tax treatment of any Common Stock acquired by exercise of an incentive stock option will depend upon whether the participant disposes of his or her shares prior to two years after the date the incentive stock option was granted or one year after the Common Stock were transferred to the participant (referred to as the “Holding Period”). If a participant disposes of Common Stock acquired by exercise of an incentive stock option after the expiration of the Holding Period, any amount received in excess of the participant’s tax basis for such shares will be treated as short-term or long-term capital gain, depending upon how long the participant has held the Common Stock. If the amount received is less than the participant’s tax basis for such shares, the loss will be treated as short-term or long-term capital loss, depending upon how long the participant has held the shares.

 

If the participant disposes of Common Stock acquired by exercise of an incentive stock option prior to the expiration of the Holding Period, the disposition will be considered a “disqualifying disposition.” If the amount received for the Common Stock is greater than the fair market value of the Common Stock on the exercise date, then the difference between the incentive stock options exercise price and the fair market value of the Common Stock at the time of exercise will be treated as ordinary income for the tax year in which the “disqualifying disposition” occurs. The participant’s basis in the Common Stock will be increased by an amount equal to the amount treated as ordinary income due to such “disqualifying disposition.” In addition, the amount received in such “disqualifying disposition” over the participant’s increased basis in the Common Stock will be treated as capital gain. However, if the price received for Common Stock acquired by exercise of an incentive stock option is less than the fair market value of the Common Stock on the exercise date and the disposition is a transaction in which the participant sustains a loss which otherwise would be recognizable under the Code, then the amount of ordinary income that the participant will recognize is the excess, if any, of the amount realized on the “disqualifying disposition” over the basis of the Common Stock.

 

Non-qualified Stock Options. A participant generally will not recognize income at the time a non-qualified stock option is granted. When a participant exercises a non-qualified stock option, the difference between the option price and any higher market value of the Common Stock on the date of exercise will be treated as compensation taxable as ordinary income to the participant. The participant’s tax basis for Common Stock acquired under a non-qualified stock option will be equal to the option price paid for such Common Stock, plus any amounts included in the participant’s income as compensation. When a participant disposes of Common Stock acquired by exercise of a non-qualified stock option, any amount received in excess of the participant’s tax basis for such shares will be treated as short-term or long-term capital gain, depending upon how long the participant has held the Common Stock. If the amount received is less than the participant’s tax basis for such shares, the loss will be treated as short-term or long-term capital loss, depending upon how long the participant has held the shares.

 

Special Rule if Option Price is Paid for in Common Stock. If a participant pays the option price of a non-qualified stock option with previously-owned shares of Common Stock and the transaction is not a disqualifying disposition of Common Stock previously acquired under an incentive stock option, the Common Stock received equal to the number of shares surrendered are treated as having been received in a tax-free exchange. The participant’s tax basis and holding period for the Common Stock received will be equal to the participant’s tax basis and holding period for the Common Stock surrendered. The Common Stock received in excess of the number of shares surrendered will be treated as compensation taxable as ordinary income to the participant to the extent of their fair market value. The participant’s tax basis in the Common Stock will be equal to their fair market value on the date of exercise, and the participant’s holding period for such shares will begin on the date of exercise.

 

25

 

 

If the use of previously acquired Common Stock to pay the exercise price of a non-qualified stock option constitutes a disqualifying disposition of Common Stock previously acquired under an incentive stock option, the participant will have ordinary income as a result of the disqualifying disposition in an amount equal to the excess of the fair market value of the Common Stock surrendered, determined at the time such Common Stock were originally acquired on exercise of the incentive stock option, over the aggregate option price paid for such Common Stock. As discussed above, a disqualifying disposition of Common Stock previously acquired under an incentive stock option occurs when the participant disposes of such shares before the end of the Holding Period. The other tax results from paying the exercise price with previously owned shares are as described above, except that the participant’s tax basis in the Common Stock that are treated as having been received in a tax-free exchange will be increased by the amount of ordinary income recognized by the participant as a result of the disqualifying disposition.

 

Restricted Stock. A participant who receives restricted stock generally will recognize as ordinary income the excess, if any, of the fair market value of the Common Stock granted as restricted stock at such time as the Common Stock are no longer subject to forfeiture or restrictions, over the amount paid, if any, by the participant for such Common Stock. However, a participant who receives restricted stock may make an election under Section 83(b) of the Code within 30 days of the date of transfer of the Common Stock to recognize ordinary income on the date of transfer of the Common Stock equal to the excess of the fair market value of such shares (determined without regard to the restrictions on such Common Stock) over the purchase price, if any, of such shares. If a participant does not make an election under Section 83(b) of the Code, then the participant will recognize as ordinary income any dividends received with respect to such Common Stock. At the time of sale of such shares, any gain or loss realized by the participant will be treated as either short-term or long-term capital gain (or loss) depending on the holding period. For purposes of determining any gain or loss realized, the participant’s tax basis will be the amount previously taxable as ordinary income, plus the purchase price paid by the participant, if any, for such shares.

 

Stock Appreciation Rights. Generally, a participant who receives a stand-alone SAR will not recognize taxable income at the time the stand-alone SAR is granted, provided, that the SAR is exempt from or complies with Section 409A of the Code. If a participant receives the appreciation inherent in the SARs in cash, the cash will be taxed as ordinary income to the recipient at the time it is received. If a participant receives the appreciation inherent in the SARs in stock, the spread between the then current market value and the grant price, if any, will be taxed as ordinary income to the employee at the time it is received. In general, there will be no federal income tax deduction allowed to the Company upon the grant or termination of SARs. However, upon the exercise of a SAR, the Company will be entitled to a deduction equal to the amount of ordinary income the recipient is required to recognize as a result of the exercise.

 

Other Awards. In the case of an award of restricted stock units, performance awards, dividend equivalent rights or other stock or cash awards, the recipient will generally recognize ordinary income in an amount equal to any cash received and the fair market value of any shares received on the date of payment or delivery, provided, that the award is exempt from or complies with Section 409A of the Code. In that taxable year, the Company will receive a federal income tax deduction in an amount equal to the ordinary income which the participant has recognized.

 

Federal Tax Withholding. Any ordinary income realized by a participant upon the exercise of an award under the 2024 LTIP is subject to withholding of federal, state and local income tax and to withholding of the participant’s share of tax under the Federal Insurance Contribution Act and the Federal Unemployment Tax Act. To satisfy federal income tax withholding requirements, the Company will have the right to require that, as a condition to delivery of any certificate for Common Stock, the participant remit to the Company an amount sufficient to satisfy the withholding requirements. Alternatively, the Company may withhold a portion of the Common Stock (valued at fair market value) that otherwise would be issued to the participant to satisfy all or part of the withholding tax obligations or may, if the Company consents, accept delivery of Common Stock with an aggregate fair market value that equals or exceeds the required tax withholding payment. Withholding does not represent an increase in the participant’s total income tax obligation, since it is fully credited toward his or her tax liability for the year. Additionally, withholding does not affect the participant’s tax basis in the Common Stock. Compensation income realized and tax withheld will be reflected on Forms W-2 supplied by the Company to employees by January 31 of the succeeding year. Deferred compensation that is subject to Section 409A of the Code will be subject to certain federal income tax withholding and reporting requirements.

 

26

 

 

Tax Consequences to the Company. To the extent that a participant recognizes ordinary income in the circumstances described above, the Company will be entitled to a corresponding deduction provided, that, among other things, the income meets the test of reasonableness, is an ordinary and necessary business expense, is not an “excess parachute payment” within the meaning of Section 280G of the Code and is not disallowed by the $1,000,000 limitation on certain executive compensation under Section 162(m) of the Code.

 

While deductibility of executive compensation for federal income tax purposes is among the factors the Board and Committee considers when structuring executive compensation arrangements, it is not the sole or primary factor considered. The Company retains the flexibility to authorize compensation that may not be deductible if we believe it is in the best interests of the Company.

 

Million Dollar Deduction Limit and Other Tax Matters. The Company may not deduct compensation of more than $1,000,000 that is paid to “covered employees” (as defined in Section 162(m) of the Code), which include an individual (or, in certain circumstances, his or her beneficiaries) who, at any time during the taxable year, is the Company’s principal executive officer, principal financial officer, an individual who is among the three highest compensated officers for the taxable year (other than an individual who was either the Company’s principal executive officer or its principal financial officer at any time during the taxable year), or anyone who was a covered employee for purposes of Section 162(m) of the Code for any tax year beginning on or after January 1, 2017. This limitation on deductions only applies to compensation paid by a publicly-traded corporation (and not compensation paid by non-corporate entities) and may not apply to certain types of compensation, such as qualified performance-based compensation, that is payable pursuant to a written, binding contract (such as an award agreement corresponding to a Prior Plan Award) that was in place as of November 2, 2017, so long as the contract is not materially modified after that date. To the extent that compensation is payable pursuant to a prior plan award granted on or before November 2, 2017, and if the Company determines that Section 162(m) of the Code will apply to any such awards, the Company intends that the terms of those awards will not be materially modified and will be constructed so as to constitute qualified performance-based compensation and, as such, will be exempt from the $1,000,000 limitation on deductible compensation.

 

If an individual’s rights under the 2024 LTIP are accelerated as a result of a change in control and the individual is a “disqualified individual” under Section 280G of the Code, then the value of any such accelerated rights received by such individual may be included in determining whether or not such individual has received an “excess parachute payment” under Section 280G of the Code, which could result in (i) the imposition of a 20% federal excise tax (in addition to federal income tax) payable by the individual on the value of such accelerated rights, and (ii) the loss by the Company of a corresponding compensation deduction.

 

Interest of Directors and Executive Officers. All members of the Board and all executive officers of the Company are eligible for awards under the 2024 LTIP and thus, have a personal interest in the approval of the 2024 LTIP.

 

Termination and Change of Control

 

For a discussion of agreements that provide for payments to a named executive officer in connection with the resignation, retirement or other termination of a named executive officer or a change of control, please see “Executive Compensation - Executive Employment Arrangements” above.

 

Director Compensation

 

Prior to the Business Combination, the Company had not adopted a formal policy or plan to compensate BEN’s directors. Mr. Luck served as a member of the Board and received no additional compensation for his service as a member of the Board. See the section titled “Executive Compensation - Summary Compensation Table” for more information about Mr. Luck’s compensation for the fiscal year ended December 31, 2025.

 

Upon the Closing Date of the Business Combination, each director of the Company received a grant of 10,000 shares of Common Stock.

 

Following the consummation of the Business Combination, the Board adopted a nonemployee director compensation program (the “2024 Director Compensation Policy”). The 2024 Director Compensation Policy is designed to align compensation with BEN’s business objectives and the creation of stockholder value, while enabling BEN to attract, retain, incentivize and reward non-employee directors who contribute to the long-term success of BEN.

 

27

 

 

On December 30, 2024, each non-employee director received an equity award of restricted stock units under the 2024 LTIP having an aggregate award value of $35,000, with the number of restricted stock units being determined by using the average of the closing prices for the Common Stock over the 20-day-trading period ending on the first trading day of August 2024.

 

For all periods after the effective date of the 2024 Director Compensation Policy, each non-employee director will receive an equity award of restricted stock, automatically granted quarterly in four equal installments, payable in arrears, on the first trading day of September, December, March, and June (each, a “Grant Date”), and having an aggregate annual award value of $45,000 as of the Grant Date, with the number of shares of restricted stock granted each quarter being determined by dividing one-fourth of the aggregate annual award value by the average of the closing prices for the Common Stock over the 20-day-trading period ending on the last trading day immediately preceding Grant Date.

 

On the date of each of the Company’s Annual Stockholders Meetings following the closing of such meeting, each non-employee director automatically will be granted an annual equity award of restricted stock units having an aggregate award value of $75,000 on the date of such Annual Stockholders Meeting, with the number of restricted stock units being determined by dividing the aggregate award value by the average of the closing prices for the Common Stock over the 20-day-trading period ending on the last trading day immediately prior to such Annual Stockholders Meeting (the “Annual RSU Award”). The Annual RSU Award will vest in full on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the next Annual Stockholders Meeting, subject to the non-employee director’s continued service on the Board through such vesting date.

 

Under the 2024 Director Compensation Policy, each of the Non-Executive Board Chair, the Audit Committee Chair, the Compensation Committee Chair, and the Nominating and Governance Committee Chair (each, a “Committee Chair”) receive an additional equity award of restricted stock to be automatically granted in four equal installments, payable in arrears, on each Grant Date, having an aggregate annual award value as $50,000 for the Non-Executive Board Chair, $20,000 for the Audit Committee Chair, $15,000 for the Compensation Committee Chair, and $10,000 for the Nominating and Governance Committee Chair, with the number of restricted shares being determined by dividing one-fourth of the aggregate annual award value by the average of the closing prices for the Common Stock over the 20-day-trading period ending on the last trading day immediately preceding the Grant Date.

 

Each of the Special Committee members of the Board receive an additional equity award of restricted stock, to be automatically granted in four equal installments, payable in arrears, on each Grant Date, and having an aggregate annual award value of $20,000, with the number of shares of restricted stock being determined by dividing one-fourth of the aggregate annual award value by the average of the closing prices for the Common Stock over the 20-day-trading period ending on last trading day immediately preceding the Grant Date.

 

On December 30, 2025, the Board approved compensation for Board service for the period from March 15, 2025 to March 14, 2026, consisting of restricted stock units with a value of $75,000 for each director and $20,000 per year for chairing a committee, in each case at $2.50 per share, and determined that directors who receive a salary as officers of the Company are not eligible for Board compensation. The restricted stock units were issued on March 18, 2026.

 

28

 

 

Non-Employee Director Compensation Table

 

Name 

Fees earned or

paid in cash ($)

   Stock awards ($)(1)   Total ($) 
Bernard Puckett   –    71,250(3)   71,250 
Jon Leibowitz   –    71,250(3)   71,250 
Richard Isaacs(5)   –    71,250(3)   71,250 
Thomas Morgan Jr.   –    61,250(3)   61,250 
Christopher Gaertner(2)   –    36,277(3)   36,277 
Ruy Carrasco(4)   –    23,750(6)   23,750 

 

(1) In accordance with SEC rules, this column represents the aggregate grant date fair value of shares underlying stock awards, calculated based on the closing price of our Common Stock on the date of grant in accordance with ASC 718, with the exception that the amounts shown assumes no forfeitures. The assumptions made in computing the estimated fair value of such awards are disclosed in Note I of the Company’s audited consolidated financial statements included in the Original Filing. 

(2) Mr. Gaertner resigned from our Board effective September 8, 2025.

(3) Represents restricted stock granted pursuant to the 2024 Director Compensation Policy for service on the Board in fiscal year 2025, based on a closing price of our Common Stock of $2.50 per share on the grant date.

(4) Dr. Carrasco was appointed to the Board on September 17, 2025. Dr. Carrasco also serves as our Chief Medical Informatics Officer and receives no compensation in that capacity.

(5) As of December 31, 2025, Dr. Isaacs held options to purchase 28,443 shares of Common Stock. No other non-employee director held options or unvested stock awards as of December 31, 2025.

(6) Represents the grant date fair value, calculated in accordance with ASC 718, of options covering 9,481 shares of Common Stock granted to Dr. Carrasco on December 30, 2025 for his service as a director in the fourth quarter of 2025, as reported in the Original Filing.

 

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information

 

We do not have a formal policy regarding the timing of awards of option awards in relation to our disclosure of material nonpublic information. However, our historic practice is to grant option awards three trading days following the release of material nonpublic information in order to prevent the release of such information from affecting the value of executive compensation. No option awards were granted to named executive officers in 2025. The option granted to Mr. Khiari as of his November 18, 2024 start date was approved by the Board by written consent effective February 25, 2025. If in the future we determine to grant new awards of options, stock appreciation rights, or similar option-like instruments, we will consider establishing a policy regarding the timing of such awards in relation to the disclosure of material non-public information, and the Board will evaluate the appropriate steps to take in relation to the foregoing.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth information regarding the beneficial ownership of shares of our Common Stock as of April 15, 2026:

 

  ● each person or “group” (as such term is used in Section 13(d)(3) of the Exchange Act) known by the Company to be the beneficial owner of more than 5% of our Common Stock as of April 15, 2026;
  ●

each of the Company’s named executive officers;

each of the Company’s directors; and

  ● all of our current executive officers and directors as a group.

 

29

 

 

As of April 15, 2026, the Company had 5,857,955 shares of Common Stock issued and outstanding. Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if such person possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares subject to such options and warrants are deemed outstanding for purposes of computing the percentage ownership of the person holding them, but are not deemed outstanding for purposes of computing the percentage of ownership of any other person. Except as otherwise indicated in the footnote below and subject to community property laws where applicable, we believe that all persons named in the table below have sole voting and investment power with respect to all shares of Common Stock beneficially owned by them. Information with respect to holders of more than 5% of our Common Stock is based on Schedules 13D and 13G filed with the SEC, except as otherwise noted. All share amounts reflect the 1-for-10 reverse stock split of our Common Stock, effective December 12, 2025. Unless otherwise indicated, the address of each person named in the table below is c/o Brand Engagement Network Inc., 300 Delaware Ave, Suite 210, Wilmington, DE 19801.

 

  

Number of shares

beneficially owned

  

Beneficial

ownership percentage

 
Five Percent Holders          
October 3rd Holdings, LLC(1)   876,556    14.96%
Joseph Bevash(2)   571,662    9.76%
BEN Capital Fund I, LLC(3)   430,600    7.35%
DMLab Co. LTD(4)   432,504    7.38%
           
Directors & Named Executive Officers          
Paul Chang(5)          
Tyler J. Luck(6)   893,521    15.25%
Walid Khiari(7)   36,154    * 
James D. Henderson, Jr.(8)   145,651    2.5%
Jon Leibowitz(9)   48,610    * 
Venkata Ramana Pinnam(10)   15,727    * 
Janine Grasso(11)   4,607    * 
Thomas Morgan Jr.(12)   48,814    * 
Ruy Carrasco, M.D.(13)   17,671    * 
Richard Isaacs, M.D.(14)   43,139    * 
All current directors and executive officers as a group (and includes October 3rd Holdings)(15)   1,253,894    21.4%

 

*Less than 1%.

 

(1) Consists of 876,556 shares held of record by October 3rd Holdings, LLC. Tyler Luck is the managing member of October 3rd Holdings, LLC and has sole voting and dispositive power over the securities held thereby. The business address of October 3rd Holdings, LLC is 1821 Logan Avenue C/O CSC Cheyenne, WY 82001.

 

(2) Based solely on a Schedule 13G filed by Joseph Bevash with the SEC on April 7, 2026. Consists of (i) 461,220 shares held of record and (ii) 110,442 shares issuable upon exercise of warrants exercisable within 60 days of April 7, 2026.

 

(3) Consists of 398,844 shares held by BEN Capital Fund I, LLC and 31,756 shares issuable upon exercise of warrants exercisable within 60 days of April 15, 2026, based on the Company’s records. In a Schedule 13G filed with the SEC on May 19, 2026, BEN Capital Fund I, LLC reported beneficial ownership of 464,923 shares of Common Stock as of May 11, 2026. James M. Irving, managing director has voting and dispositive power over such shares.

 

(4) Based solely on the asset purchase agreement details with DMLab Co. LTD dated May 3, 2023. Consists of 432,504 shares held of record after adjusting for the reverse stock split in December 2025..

 

(5) Based on Company records, Mr. Chang did not beneficially own any shares of Common Stock as of April 15, 2026.

 

(6) Consists of 16,965 shares held of record by Mr. Luck, (ii) the 876,556 shares held by October 3rd Holdings, LLC described in footnote (1)

 

30

 

 

(7) Consists of (i) 14,904 shares held of record by Mr. Khiari and (ii) 21,250 shares issuable upon exercise of options exercisable within 60 days of April 15, 2026.

 

(8) Consists of 145,786 shares held of record by Mr. Henderson. 5,402 warrants were exercised in January, 2026. No additional warrants are held by Mr. Henderson

 

(9) Consists of 48,610 shares held of record by Mr. Leibowitz.

 

(10) Consists of 15,727 shares held of record by Mr. Pinnam.

 

(11) Consists of 4,607 shares held of record by Ms. Grasso.

 

(12) Consists of 4,022 shares held of record by Mr. Morgan and 24,191 shares held by Pacific Premier Trust and Morgan Land LLC, over which Mr. Morgan may be deemed to have voting and dispositive power.

 

(13) Consists of 17,671 shares held of record by Dr. Carrasco.

 

(14) Consists of (i) 31,367 shares held of record by Dr. Isaacs and (ii) 12,155 shares issuable upon exercise of options to purchase shares of Common Stock exercisable within 60 days of April 15, 2026.

 

(15) Consists of 1,253,894 shares held by our current directors and executive officers as a group, including the shares held by October 3rd Holdings, and 53,623 shares issuable upon exercise of options and warrants exercisable within 60 days of April 15, 2026.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

Equity Compensation Plan Information

 

The following table provides information as of December 31, 2025, about compensation plans under which shares of Common Stock may be issued to employees, executive officers or members of our Board of Directors upon the exercise of options, warrants or rights under all of our existing equity compensation plans.

 

   Equity Compensation Plan Information 
Plan category 

Number of

securities to be

issued upon exercise

of outstanding

options, warrants

and rights

(a)

  

Weighted-average

exercise price of

outstanding options,

warrants and rights

(b)(2)

  

Number of securities remaining available for future issuance

under equity

compensation plans

(excluding

securities reflected

in column (a))

(c)(1)

 
Equity compensation plans approved by security holders(1)   464,244   $-    26,616 
Equity compensation plans not approved by security holders(3)   2,341,759    2.09    0 
Total   2,806,003    2.09    26,616 

 

(1) Represents shares of Common Stock available for issuance under the 2024 LTIP, which permits the issuance of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, dividend equivalent rights, performance awards, performance goals, tandem awards, prior plan awards, and other awards. As described below, no additional awards may be issued under the 2024 LTIP. See the description of the 2021 LTIP below for a description of the formula for calculating the number of securities available for issuance under the 2024 LTIP.

 

31

 

 

(2) Represents shares of Common Stock issuable upon settlement of outstanding restricted equity units awarded under the 2021 Equity Incentive Plan.

 

(3) As described below, no additional awards may be issued under the 2021 Equity Incentive Plan. The 2021 Equity Incentive Plan and all outstanding awards under the 2021 Equity Incentive Plan were assumed by the Company, and the 2021 Equity Incentive Plan was terminated with respect to future awards. Forfeitures of awards under the 2021 Equity Incentive Plan are automatically added to the pool of shares available for issuance under the 2024 LTIP.

 

Plans Not Approved by Security Holders

 

None, except that between August 22, 2024 and December 31, 2025, awards of stock options to purchase certain shares of common stock were issued to entities controlled by officers, directors, employees or consultants (“Entity Awards”), rather than solely to natural persons as required by the 2024 LTIP. Such issuances may be deemed to constitute a material amendment of the 2024 LTIP or the establishment of equity compensation arrangements outside the 2024 LTIP, in either case for which shareholder approval was not obtained. The Board has suspended further issuances of equity awards under the 2024 LTIP to non-natural persons and is evaluating a remediation plan with respect to the Entity Awards.

 

Plans Approved by Security Holders

 

2021 Equity Incentive Plan

 

In May 2021, the Board adopted, and the Company’s stockholders approved, the 2021 Equity Incentive Plan that provides for the grant of the following types of stock awards: (i) incentive stock Options, (ii) non-statutory stock options, (iii) stock appreciation rights, (iv) restricted stock awards, (v) restricted stock unit awards, and (vi) other stock awards. The 2021 Option Plan was administered by the Company’s Board of Directors (the “Board of Directors”). In connection with the Closing of the Business Combination, the 2021 Equity Incentive Plan and all outstanding awards under the 2021 Equity Incentive Plan were assumed by the Company, and the 2021 Equity Incentive Plan was terminated with respect to future awards. Forfeitures of awards under the 2021 Equity Incentive Plan are automatically added to the pool of shares available for issuance under the 2024 LTIP. Upon Closing, each stock award was adjusted in accordance with the Exchange Ratio (as defined herein).

 

2024 LTIP

 

On the Closing Date, the 2024 LTIP became effective. The 2024 LTIP was approved by DHC’s stockholders at the Special Meeting. The 2024 LTIP provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) nonqualified stock options, (iii) stock appreciation rights, (iv) restricted stock, (v) restricted stock units, (vi) performance awards, (vii) dividend equivalent rights, (viii) performance awards, (ix) performance goals, (x) tandem awards, (xi) prior plan awards, and (xii) other awards. The 2024 LTIP is administered by the Board of Directors. The 2024 LTIP awards are available to employees, officers and contractors. Subject to certain adjustments and any increase by any Prior Plan Awards eligible for reuse as described below, the aggregate number of shares of our Common Stock issuable under the 2024 LTIP in respect of awards is equal to 5% of the aggregate number of shares issued and outstanding determined as of the Effective Date, which as of such date was 2,942,245 shares of Common Stock, of which 100% of the available shares may be delivered pursuant to incentive stock options. Notwithstanding the foregoing, subject to approval by the Board, on the Adjustment Date, the number of shares of our Common Stock available under the 2024 LTIP may be increased by up to an additional 5% of the total number of shares issued and outstanding, as determined as of the Adjustment Date, provided, however, in no event shall the authorized shares available for awards under the 2024 Plan ever exceed 15% of the total number of shares of our Common Stock issued and outstanding, determined as of the Effective Date, provided, further, however, that no such adjustment shall have any effect on, or otherwise change the ISO Limit, except for any adjustments summarized below. As of December 31, 2025, 26,616 shares remained available for grant under the 2024 LTIP.

 

32

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

In addition to the various agreements and arrangements discussed in the sections titled “Directors, Executive Officers and Corporate Governance” and “Executive Compensation,” the following is a description of each transaction since January 1, 2024 and each currently proposed transaction in which:

 

  ● The Company has been or is to be a participant;
  ● the amount involved exceeded or exceeds the lesser of (a) $120,000 or (b) one percent of the average of the Company’s total assets at year-end for the last two completed fiscal years; and
  ● any of the Company’s directors, executive officers or beneficial holders of more than 5% of its capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.

 

All share and per share amounts in this Item 13 give effect to the 1-for-10 reverse stock split of the Common Stock effected in December 2025 (the “Reverse Stock Split”), including amounts relating to transactions that occurred before the Reverse Stock Split. Share and per share amounts for transactions that occurred on or after the effective date of the Reverse Stock Split are presented as issued and have not been further adjusted. Amounts relating to securities of Prior BEN issued before the Business Combination are presented on a historical basis.

 

Except as otherwise indicated, the information in this Item 13 is presented as of April 15, 2026, the date of the Original Filing, and does not reflect transactions or events occurring after that date.

 

Howard Consulting Services Agreement

 

On October 1, 2021, prior to the start of Mr. James Richard Howard’s service as Chief Information and Data Officer in November of 2023, the Company entered into a Consulting Services Agreement, as amended effective July 1, 2023, with RG Data Insights, LLC, a consulting firm that employed Mr. Howard, pursuant to which Mr. Howard acted as a consultant to the Company. The Consulting Services Agreement expired on September 30, 2023. In connection with the Consulting Services Agreement, as amended, the Company agreed to pay Mr. Howard a $0.15 million success fee upon the completion of a successful capital raise in excess of $5.0 million. Additionally, the Company agreed to issue Mr. Howard a Compensatory Warrant to purchase up to 30,000 shares of Prior BEN’s Class B common stock (“Prior BEN Common Stock”) at an exercise price of $1.00 per share, provided, that Mr. Howard continued to be an advisory board member to the Company through September 30, 2024.

 

Mr. Howard served as Chief Information and Data Officer until June 30, 2025, at an annual salary of $350,000. At the time of his departure, Mr. Howard agreed to convert $58,333.00 of his salary, as well as the success fee noted hereinabove, into 11,457 shares of common stock issued on July 17, 2025, at $3.30 per share.

 

Following his departure as Chief Information and Data Officer, Mr. Howard continued to act as Consultant for the Company at $10,000 per month for a three-month period. In late December 2025, Mr. Howard converted the $30,000 fees earned as a Consultant into 14,285 shares of common stock at $2.10 per share.

 

Transactions with October 3rd Holdings, LLC

 

October 3rd Holdings, LLC owns a 52.4025% interest in Genuine Lifetime, LLC, of which Mr. Michael Lucas and Mr. James D. Henderson, Jr. own respective 6.7235% and 11.813% interests. Due Figlie, LLC which is controlled by Shawn Lucas, owns a 10% interest in Genuine Lifetime, LLC. October 3rd Holdings, LLC is co-owned in equal 50% shares by Mr. Tyler Luck and his spouse Mr. Lucas. Mr. Luck served as Managing Member of Genuine Lifetime, LLC until June 1, 2023. In connection with the Company’s entry into the Reseller Agreement with AFG, Genuine Lifetime, LLC issued 500,000 shares of Prior BEN Common Stock to AFG in connection with the Reseller Agreement pursuant to a separate agreement between Genuine Lifetime, LLC and AFG. In connection with the GL Interim Financing, Genuine Lifetime, LLC entered into a promissory note with AFG pursuant to which AFG agreed to lend, and Genuine Lifetime, LLC agreed to borrow, $4.0 million in order to fund the GL Interim Financing (the “GL Loan”), and the GL Loan agreement required that the proceeds be used solely to purchase shares of common stock. In connection with the GL Loan, Mr. Luck entered into a personal guaranty with respect to Genuine Lifetime, LLC’s obligations under the GL Loan. Additionally, Mr. Luck, agreed not to sell, transfer or assign his shares of Common Stock, or permit October 3rd Holdings, LLC, as its managing member to sell, transfer or assign its shares of Common Stock, prior to the repayment of the GL Loan, subject to certain customary exceptions including a sale of such shares of Common Stock by Mr. Luck and October 3rd Holdings, LLC in connection with the consummation of the Business Combination.

 

33

 

 

In addition, effective June 30, 2024, Prior BEN and the Company entered into a Debt Conversion Agreement with October 3rd Holdings, LLC, pursuant to which the Company agreed to issue 9,333 shares of Common Stock at a price of $45.00 per share to October 3rd Holdings, LLC in exchange for the conversion of certain outstanding indebtedness owed by a subsidiary of the Company to October 3rd Holdings, LLC in the amount of approximately $0.4 million.

 

Transactions with AFG Companies, Inc.

 

AFG Companies, Inc. (“AFG”) beneficially owned more than 5% of the Common Stock from the closing of the Business Combination on March 14, 2024 until the first quarter of 2026, when, according to a Schedule 13G filed with the SEC on May 15, 2026 by AFG and Ralph Wright Brewer III, AFG’s beneficial ownership fell below 5% following dispositions of Common Stock. Mr. Brewer is the Chief Executive Officer of AFG and may be deemed to share voting and dispositive power over the shares of Common Stock held by AFG.

 

On August 19, 2023, Prior BEN entered into an Exclusive Reseller Agreement with AFG, which was amended on February 9, 2024 (as amended, the “Reseller Agreement”), pursuant to which AFG agreed to act as the exclusive channel partner and reseller of the Company’s software-as-a-service products in the motor vehicle marketing and manufacturing industry for a term of five years. As partial consideration for AFG’s services under the Reseller Agreement, (i) Prior BEN issued to AFG shares of Prior BEN Common Stock that converted in the Business Combination into 175,000 shares of Common Stock, which had an aggregate fair value of $13,475,000 based on the closing price of the Common Stock on March 14, 2024, and (ii) the Company issued to AFG a non-transferable warrant to purchase up to 375,000 shares of Common Stock at an exercise price of $100.00 per share, which would vest based on revenues from sales of the Company’s products paid by AFG to the Company under the Reseller Agreement (the “Reseller Warrant”). AFG paid the Company an aggregate of $0 under the Reseller Agreement during 2024 and 2025. On January 17, 2025, the Company delivered a notice to AFG terminating the Reseller Agreement, and the Reseller Warrant was cancelled. In connection with the termination, the Company recorded an impairment of deferred customer acquisition costs of $13,475,000 for the year ended December 31, 2024, relating to the shares issued to AFG under the Reseller Agreement.

 

On September 7, 2023, Prior BEN entered into a Subscription Agreement with AFG (the “AFG Subscription Agreement”), pursuant to which AFG agreed (i) to purchase shares of Prior BEN Common Stock immediately prior to the closing of the Business Combination for an aggregate purchase price of $6.5 million, which shares converted in the Business Combination into the right to receive 65,000 shares of Common Stock, and (ii) to purchase additional shares of Common Stock in four annual installments of $6.5 million each, for an aggregate purchase price of $26.0 million, beginning in March 2025, at a purchase price per share equal to the lesser of $21.10 and the average of the last reported sales prices of the Common Stock for the 20 trading days immediately preceding the applicable installment purchase date, subject to a floor price of $21.10 per share. On September 29, 2023, AFG paid $1.0 million of its initial purchase obligation through the purchase of shares of Prior BEN Common Stock, and AFG paid the remaining $5.5 million immediately prior to the closing of the Business Combination on March 14, 2024. AFG did not fund the first installment of $6.5 million due in March 2025, and the Company has not issued any shares of Common Stock to AFG under the installment provisions of the AFG Subscription Agreement.

 

On January 16, 2025, the Company filed a lawsuit against AFG and Mr. Brewer in the U.S. District Court for the Northern District of Texas, Dallas Division, alleging fraudulent misrepresentation, breach of contract and the concealment of a ransomware attack on AFG’s network shortly before the Reseller Agreement was executed. On March 26, 2025, the Company filed a First Amended Complaint against AFG in the U.S. District Court for the Southern District of New York alleging breach of the AFG Subscription Agreement based on AFG’s failure to fund the $6.5 million installment due on March 13, 2025. On May 12, 2025, AFG filed an answer denying the allegations and asserting counterclaims against the Company for an unspecified amount of damages. The litigation remains pending.

 

34

 

 

AFG Companies, Inc. has failed to fund the $6.5 million installment payments due under the September 7, 2023, Subscription Agreement in both March 2025 and March 2026. AFG remains contractually obligated to fund an additional $6.5 million in March 2027 and $6.5 million in March 2028. The agreement contains a minimum purchase price floor of $2.10 per share (pre-reverse split), which equates to $21.10 per share following the Company’s December 2025 1-for-10 reverse stock split. Any shares issued upon enforcement of the remaining obligations would therefore be issued at a price of at least $21.10 per share, substantially above the Company’s recent trading price of approximately $4.60. The non-receipt of the 2025 and 2026 payments has materially strained the Company’s liquidity and constrained product development and commercial activities. Litigation seeking to enforce the Subscription Agreement is pending; recovery of the unpaid and remaining amounts is uncertain.

 

In addition, as described under “Transactions with October 3rd Holdings, LLC” above, in connection with the Reseller Agreement and the GL Interim Financing, Genuine Lifetime, LLC issued shares of Prior BEN Common Stock to AFG and borrowed $4.0 million from AFG under the GL Loan, and Mr. Luck personally guaranteed Genuine Lifetime, LLC’s obligations under the GL Loan. As of December 31, 2025, the outstanding principal amount of the GL Loan was $4,000,000 though the validity of the loan is subject to litigation, which litigation remains pending.

 

Lucas Consulting Arrangements

 

Pursuant to a consulting agreement dated June 1, 2023, and in exchange for certain consulting, strategic and advisory services previously provided through May 31, 2023, Mr. Lucas, the spouse of Mr. Luck, received a warrant to purchase 1,500,000 shares of Prior BEN Common Stock with an exercise price of $1.00 per share, which was converted in connection with the Business Combination into an option to purchase 40,515 shares of Common Stock at an exercise price of $37 per share. In addition, any future compensation under this consulting agreement will be based on the value of any future transaction approved by the Company and said compensation shall be in the sole discretion of our board of directors.

 

Mr. Lucas also provides consulting services to the Company through L5, LLC (“L5”), an entity of which he is the managing member, pursuant to a consulting agreement dated September 26, 2023, as amended. Since July 1, 2024, the consulting agreement has provided for a monthly consulting fee of $10,000 payable to L5. Effective December 31, 2025, L5 merged with Eleven7 Holdings, LLC (“Eleven7”), of which Mr. Lucas is the managing member, and Eleven7 succeeded to L5’s rights under the consulting agreement. Since January 1, 2024, L5 and Eleven7 have elected to receive shares of Common Stock issued in lieu of cash payment of consulting fees owed by the Company, as follows:

 

Election Date  Fees Converted  

Conversion

Price per Share

   Shares Issued   Holder 
May 1, 2025  $100,000   $3.60(1)   27,777    L5 
June 30, 2025  $10,000   $4.40(1)   2,272    L5 
October 2, 2025  $30,000   $3.30(2)   9,090    L5 
December 20, 2025  $350,000   $2.10(2)   166,666    L5 
January 23, 2026  $30,000   $16.58(1)   1,809(3)   Eleven7 
Total  $520,000         207,614      

 

(1) Closing price of the Common Stock on the election date, as provided in the applicable election form.

(2) Price agreed upon by the Company and L5, as provided in the applicable election form.

(3) Issued on June 29, 2026.

 

Private Placements and Other Financing Transactions

 

Since January 1, 2024, the Company has funded its operations in significant part through private placements of Common Stock and warrants, inducements for the exercise of outstanding warrants, short-term loans, and the conversion of indebtedness into Common Stock. Certain of the investors in these transactions are, or were at the time of the applicable transaction, related persons of the Company, as described below.

 

Relationships of Participating Investors

 

Michael Lucas, a co-founder of and consultant to the Company, is the spouse of Tyler J. Luck, the Company’s Chief Executive Officer and a member of the Board. October 3rd Holdings, LLC, a beneficial owner of more than 5% of the Common Stock, is owned in equal shares by Mr. Luck and Mr. Lucas. Mr. Luck has sole voting and dispositive power over the shares held by October 3rd Holdings, LLC.

 

35

 

 

The Company has determined to treat each of BEN Capital Fund I, LLC (“BCF I”) and Due Figlie LLC (“Due Figlie”) as a related person for purposes of this Item 13.

 

Due Figlie. Due Figlie is controlled by its managing member, Shawn Lucas, the brother of Mr. Lucas and the brother-in-law of Mr. Luck.

 

Thomas Morgan Jr., a member of the Board, is the Managing Member of each of Corps Cap Diversified Income Fund, Corps Capital BDC, LLC and Corps Cap Advisors, LLC (collectively, the “Corps Cap Entities”).

 

May 2024 Private Placement

 

On May 28, 2024, the Company entered into a Securities Purchase Agreement (the “May SPA”) with certain investors (the “May Purchasers”), pursuant to which the Company agreed to issue and sell to the May Purchasers an aggregate of 198,000 shares of Common Stock at a purchase price of $25.00 per share, together with one-year warrants and five-year warrants to purchase up to 198,000 shares of Common Stock each, with an exercise price of $25.00 per share (collectively, the “May Warrants”), for an aggregate purchase price of $4,950,000. Following an initial closing on May 30, 2024, the remaining shares and May Warrants were held in escrow and released as the May Purchasers paid monthly installments, with one share and two May Warrants released for each $25.00 paid. Under the May SPA, the May Purchasers were entitled to designate a non-voting observer to the Board for so long as they made all required fundings, and to designate a voting member of the Board upon funding the full aggregate purchase price.

 

The May Purchasers included BCF I and Due Figlie. The following table presents the number of shares of Common Stock subscribed for by these purchasers, the aggregate subscription price, the amount paid in cash, the amount credited under the Claims Assignment Agreement described in note (2) below, and the number of May Warrants issuable to these purchasers:

 

Investor 

Shares Subscribed

  

Aggregate

Subscription Price

   Cash Paid  

Claims

Assignment Credit

  

May Warrants

 
BEN Capital Fund I, LLC(1)   41,600   $1,040,000   $715,000   $300,000    83,200 
Due Figlie LLC(2)   35,550   $888,750   $763,750   $200,000    71,100 

 

(1) BCF I paid in installments between June 26, 2024, and January 10, 2025. In June 2025, the Board approved the exchange of 6,901 restricted shares of Common Stock held by BCF I for an equal number of unrestricted shares held in the escrow account established in connection with the Company’s August 2024 private placement.

(2) Due Figlie paid in installments between June 10, 2024, and January 3, 2025. On January 14, 2025, the Company entered into a Claims Assignment Agreement with Due Figlie, pursuant to which Due Figlie assigned to the Company certain claims against AFG Companies, Inc. and its affiliates, and the Company agreed to purchase the claims for $525,000. The purchase price was offset against the obligations of Due Figlie ($200,000), BCF I ($300,000) and another May Purchaser ($25,000) under the May SPA, and the Company acknowledged receipt in full of all payments owed by those purchasers under the May SPA. The Company also agreed to indemnify Due Figlie and Shawn Lucas against any cross-complaint or other claim by AFG based on the assigned claims or their assignment. The Company recorded the $525,000 purchase price as a general and administrative expense for the year ended December 31, 2025. Due Figlie’s one-year May Warrants expired unexercised.

 

August 2024 Private Placement

 

On August 26, 2024, the Company entered into a Securities Purchase Agreement (the “August SPA”) with certain investors (the “August Purchasers”), which included BEN Capital Fund I, LLC, Joseph Bevash, Due Figlie and, pursuant to which the Company agreed to issue and sell to the August Purchasers an aggregate of 118,500 shares of Common Stock at a purchase price of $50.00 per share, for an aggregate purchase price of $5,925,000. On August 26, 2024, the Company issued 5,000 of these shares to the August Purchasers for $250,000 and issued the remaining 113,500 shares into an escrow account on the books of the Company’s transfer agent (the “Share Escrow Account”).

 

36

 

 

The August Purchasers agreed to pay the balance of the purchase price in eight monthly installments due between September 5, 2024 and April 5, 2025, and the Company agreed to release one share from the Share Escrow Account to the August Purchasers for each $50.00 paid. If an August Purchaser failed to pay its portion of any installment when due, its entire remaining commitment would become immediately due and payable. The August SPA also provided that the Letter Agreement to Exercise Warrants, dated May 28, 2024, between the Company and certain purchasers party thereto would terminate automatically upon the Company’s receipt of $3,250,000 of cash proceeds under the August SPA.

 

In connection with the August SPA, on August 26, 2024, the Company entered into a share assignment and lockup release agreement with the August Purchasers, certain members of DHC Sponsor, LLC (the “Sponsor”) and certain other existing stockholders and affiliates of the Company (collectively, the “Sponsor Members”). As an inducement to the August Purchasers to enter into the August SPA, the Sponsor Members assigned to the August Purchasers their rights, title and interest in an aggregate of 118,500 shares of Common Stock held by the Sponsor on their behalf (the “Assigned Shares”), and the Company agreed to release an aggregate of 125,250 shares of Common Stock from the transfer restrictions in a letter agreement among DHC Acquisition Corp, the Sponsor and the other parties thereto and in certain lock-up agreements entered into in connection with the Business Combination. The Sponsor Members agreed to transfer 5,000 of the Assigned Shares to the August Purchasers and the remaining 113,500 Assigned Shares into the Share Escrow Account, to be released to the August Purchasers on a pro rata basis as the installments under the August SPA were paid. If an August Purchaser failed to pay an installment, a pro rata portion of the Assigned Shares would be released from the Share Escrow Account to the Company for cancellation. The Sponsor Members also agreed that, until the earlier of March 14, 2025 and the completion of certain liquidity events, they would not transfer shares of Common Stock in an amount exceeding 25% of the average daily trading volume of the Common Stock on the date of the transfer. Thomas Morgan Jr., a member of the Board, was a member of the Sponsor.

 

Also on August 26, 2024, the Company entered into a warrant purchase agreement with certain warrant holders (the “Warrant holders”), pursuant to which the Company issued to the Warrant holders five-year warrants to purchase an aggregate of 96,000 shares of Common Stock at an exercise price of $50.00 per share. The Warrant holders included Joseph C Cohen Trust, LionCompass LLC, L5 Irrevocable Shareholder Trust and Watch Out! Shareholder Trust. Blake Lucas, the step-son of Mr. Luck, is the Trustee for the Watch Out! Shareholder Trust. In connection with the August SPA, the Board appointed Dr. Isaacs to the Board, effective August 26, 2024.

 

January 2025 Warrant Exercise Agreement

 

On January 13, 2025, the Company entered into a Warrant Exercise and Reload Agreement (the “Warrant Exercise Agreement”) with certain of the May Purchasers, pursuant to which the exercise price of specified May Warrants (the “Committed Warrants”) was reduced to $19.60 per share until May 30, 2025, and the participating purchasers agreed to exercise the Committed Warrants for cash on or before January 31, February 28 and March 27, 2025. For each Committed Warrant exercised, the Company agreed to issue two reload warrants, consisting of a two-year warrant and a five-year warrant, each with an exercise price of $17.10 per share, and to release to the exercising purchaser one share of Common Stock from the escrow account established in connection with the Company’s August 2024 private placement. Upon a purchaser’s timely completion of its required exercises, its remaining May Warrants became exercisable at $19.60 per share for the remainder of their term. Under the Warrant Exercise Agreement, BCF I and Due Figlie agreed to exercise Committed Warrants for aggregate exercise prices of approximately $504,627 and $511,425, respectively. The following table presents the number of Committed Warrants exercised and the aggregate exercise price paid by these purchasers:

 

Investor 

Committed

Warrants Exercised

  

Aggregate

Exercise Price

  

Escrow

Shares Received

  

Reload

Warrants Received

 
BEN Capital Fund I, LLC(1)   24,217   $474,666    24,217    48,434 
Due Figlie LLC(2)   0   $0    0    0 

 

(1) Exercised in installments between February 4, 2025, and March 31, 2025.

(2) Due Figlie did not exercise any Committed Warrants.

 

37

 

 

Loans from Entities Affiliated with Thomas Morgan Jr.

 

Between May 14, 2025 and July 10, 2025, the Company entered into six loan agreements with the Corps Cap Entities pursuant to which the Corps Cap Entities loaned the Company an aggregate of $500,000. Each loan bore interest at a rate of 12% per annum (18% per annum on overdue amounts) and was repayable in full, together with interest, within 180 days. The three loans made on July 10, 2025, as amended and restated, also required payment of a loan fee equal to 10% of the principal amount. As originally executed, the loan agreements entered into on July 10, 2025 provided that, as additional consideration for the loans, the Company would issue to the applicable Corps Cap Entities warrants to purchase an aggregate of 42,857 shares of Common Stock at an exercise price of $3.50 per share, exercisable six months after issuance. On July 10, 2025, the Company and the applicable Corps Cap Entities amended and restated those loan agreements to replace the warrants with the loan fee described above, and no warrants were issued. On December 17, 2025, Corps Cap BDC, LLC loaned the Company an additional $10,000, repayable within 45 days together with a loan fee of $2,000.

 

Lender  Loan Date  Principal   Loan Fee  

Warrants Issued

Corps Cap Diversified Income Fund  May 14, 2025  $150,000    None   None
Corps Cap Diversified Income Fund  May 16, 2025  $50,000    None   None
Corps Capital BDC, LLC  June 20, 2025  $50,000    None   None
Corps Cap Diversified Income Fund  July 10, 2025  $100,000   $10,000   None
Corps Cap Advisors, LLC  July 10, 2025  $25,000   $2,500   None
Corps Cap Advisors, LLC  July 10, 2025  $125,000   $12,500   None
Corps Cap BDC, LLC  December 17, 2025  $10,000   $None   None
Total     $510,000   $25,000   None

 

The largest aggregate amount of principal outstanding under these loans since January 1, 2024, was $510,000. On December 17, 2025 the loans between the Corps Cap Entities and the Company were sold and assigned by the Corps Cap Entities to BEN Capital Fund I, LLC excluding the December 17, 2025 loan in the amount of $10,000 and the loan fee and interest were waived. The Company satisfied all amounts then outstanding under the six loans made between May 14, 2025, and July 10, 2025, consisting of $500,000 of principal, $30,767 of accrued interest and $25,000 of loan fees, by issuing 264,650 shares of Common Stock at a conversion price of $2.10 per share to BEN Capital Fund I, LLC. On January 28, 2026, the Company repaid the December 17, 2025, loan in cash to Corps Cap BDC, LLC. As of April 15, 2026, no principal was outstanding under these loans.

 

On June 5, 2025, the Company also entered into a Line of Credit Agreement with Corps Capital Advisors, LLC providing for advances of up to $3,500,000 at a fixed interest rate of 10.0% per annum, maturing December 5, 2025. The Company agreed to pay Corps Capital Advisors, LLC a structuring fee of $10,000, payable on the maturity date, which was paid January 26, 2026. No amounts were drawn under the line of credit, and the line of credit expired in accordance with its terms on December 5, 2025.

 

38

 

 

Conversions of Indebtedness

 

In addition to the conversions by October 3rd Holdings, LLC, L5, Eleven7 and the Corps Cap Entities described above, the Company has converted indebtedness and other obligations owed to the following related persons into shares of Common Stock:

 

Holder  Date   Amount Converted   Conversion Price   Shares Issued  

Warrants Issued

 
James D. Henderson, Jr.(1)   May 1, 2025   $150,000   $3.60    41,666    None 
BEN Capital Fund I, LLC(2)   Dec. 17, 2025   $504,684   $2.10    240,326    None 
BEN Capital Fund I, LLC(3)   Dec. 20, 2025   $279,384   $2.10    133,040    133,040 
BEN Capital Fund I, LLC(4)   Jan. 26, 2026   $340,000   $25.00    13,600    None  

 

(1) Represents the conversion of accrued compensation, consisting of fees payable by the Company to Mr. Henderson, into shares of Common Stock issued under the 2024 LTIP at the closing price of the Common Stock on May 1, 2025.

(2) Represents the conversion of matured promissory notes, including principal, accrued interest and loan fees, in full satisfaction of the Company’s obligations under such notes.

(3) Issued under a conversion agreement dated December 20, 2025. The warrants have an exercise price equal to the conversion price and a term of 90 days.

(4) Represents the conversion of a short-term loan.

 

2026 Warrant Exercises

 

From January 1, 2026 through April 15, 2026, the following related persons exercised outstanding warrants for cash:

 

Holder  Date   Shares   Exercise Price  

Aggregate

Exercise Price

 
BEN Capital Fund I, LLC   Jan. 27, 2026    28,000   $25,000   $700,000 
James D. Henderson, Jr.   Jan. 29, 2026    5,402   $37.00   $199,874 
Shawn Lucas(1)   Jan. 29, 2026    2,800   $37.00   $103,600 
BEN Capital Fund I, LLC   Mar. 24, 2026    41,665   $3.00   $124,995 
BEN Capital Fund I, LLC    Mar. 31, 2026    240,325   $2.10   $504,683 

 

(1) Shares were issued to Due Figlie.

 

January 2026 Private Placement

 

On January 29, 2026, the Company entered into a Securities Purchase Agreement with BCF I, pursuant to which the Company agreed to issue and sell to BCF I 24,000 shares of Common Stock at a purchase price of $63.25 per share, for an aggregate purchase price of $1,518,000, payable in three equal installments of $506,000. The Board approved the purchase price as a premium to the market price of the Common Stock. No warrants were issued in connection with the private placement. BCF I paid the full purchase price on or before March 9, 2026.

 

Registration and Shareholder Rights

 

Pursuant to a registration rights and shareholder rights agreement signed March 4, 2021, the Sponsor is entitled to certain registration rights with respect to the Private Placement Warrants, the warrants issuable upon conversion of working capital loans (if any) and Common Stock issuable upon exercise of the foregoing and upon conversion of the DHC Class B Shares, par value $0.0001 per share, of DHC and, as a result of the Business Combination had the right to nominate two (2) individuals for election to our board of directors, as long as the Sponsor holds any securities covered by the registration and shareholder rights agreement.

 

In connection with the Business Combination, the Registration Rights Agreement dated March 4, 2021, by and between DHC, Sponsor and certain other equity holders named therein was amended and restated. Pursuant to the Amended and Restated Registration Rights Agreement, dated March 14, 2024 by and among the Company and the holders party thereto (the “A&R Registration Rights Agreement”), the Company agreed to register for resale, pursuant to Rule 415 under the Securities Act, certain shares of Common Stock and other equity securities of the Company that are held by the parties thereto from time to time.

 

In addition, under each of the May SPA and the August SPA, and under the warrant purchase agreement entered into in connection with the August SPA, the Company agreed to use commercially reasonable efforts to file a registration statement on Form S-1 covering the resale of the shares of Common Stock issued, or issuable upon exercise of warrants issued, thereunder and to use commercially reasonable efforts to cause the registration statement to be declared effective. The Securities Purchase Agreement, dated January 29, 2026, between the Company and BCF I grants BCF I piggyback registration rights.

 

39

 

 

Policies and Procedures for Related Party Transactions

 

On March 14, 2024, the Company adopted a written Related Party Transaction Policy that sets forth the following policies and procedures for the review and approval or ratification of related person transactions. Notwithstanding the adoption of such policy, however, the Company has been out of compliance with Nasdaq Listing Rule 5630, which requires review and oversight of related party transactions by the audit committee or another independent body of our board. Such non-compliance reflects a general failure in recent periods to follow the Related Party Transaction Policy or any other process under which our Audit Committee would review related party transactions for potential conflicts of interest before they were completed. The Company has since taken steps to help ensure compliance with the Related Party Transaction Policy going forward.

 

The terms of the Related Party Transaction Policy are as follows:

 

A “Related Person Transaction” is a transaction, arrangement or relationship in which the Company or any of its subsidiaries was, is or will be a participant, the amount of which involved exceeds the lesser of $120,000 or one percent of the average of the Company’s total assets at year-end for the last two completed fiscal years, and in which any related person had, has or will have a direct or indirect material interest. A “Related Person” means:

 

  ● any person who is, or at any time during the applicable period was, one of the Company’s officers or one of the Company’s directors;
  ● any person who is known by the Company to be the beneficial owner of more than five percent (5%) of its voting stock;
  ● any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, daughter-in-law, brother-in-law or sister-in-law of a director, officer or a beneficial owner of more than five percent (5%) of its voting stock, and any person (other than a tenant or employee) sharing the household of such director, officer or beneficial owner of more than five percent (5%) of its voting stock; and
  ● any firm, corporation or other entity in which any of the foregoing persons is a partner or principal or in a similar position or in which such person has a ten percent (10%) or greater beneficial ownership interest.

 

Under the Company’s related party transaction policy, if a transaction has been identified as a Related Person Transaction, including any transaction that was not a Related Person Transaction when originally consummated or any transaction that was not initially identified as a Related Person Transaction prior to consummation, the Company’s management must present information regarding the Related Person Transaction to the Company’s audit committee, or, if audit committee approval would be inappropriate, to another independent body of the board of directors, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the Related Persons, the benefits to the Company of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, the Company will collect information that the Company deems reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable the Company to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under the Company’s Code of Business Conduct and Ethics, the Company’s employees and directors have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering Related Person Transactions, the Company’s audit committee, or other independent body of the board of directors, will take into account the relevant available facts and circumstances including, but not limited to:

 

  ● the risks, costs and benefits to the Company;
  ● the impact on a director’s independence in the event that the Related Person is a director, immediate family member of a director or an entity with which a director is affiliated;
  ● the availability of other sources for comparable services or products; and
  ● the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.

 

The policy requires that, in determining whether to approve, ratify or reject a Related Person Transaction, the Company’s audit committee, or other independent body of the Company’s board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, the Company’s best interests and those of the Company’s stockholders, as the Company’s audit committee, or other independent body of the Company’s board of directors, determines in the good faith exercise of its discretion.

 

40

 

 

Part IV

 

Item 15. Exhibits and Financial Statement Schedules

 

Unless otherwise indicated, each document incorporated by reference was filed by the Company (or, prior to the closing of its business combination on March 14, 2024, by DHC Acquisition Corp) under Commission File No. 001-40130. Documents identified in the “Form” column as Form S-1 or Form S-1/A were filed under Registration No. 333-278673.

 

Exhibit Number   Description of Document   Filed Herewith   Incorporated by Reference   Form   Exhibit No.   Date Filed
Business Combination and Acquisition Agreements                    
2.1 # Business Combination Agreement and Plan of Reorganization, dated as of September 7, 2023, by and among Brand Engagement Network Inc., BEN Merger Subsidiary Corp., DHC Acquisition Corp and, solely with respect to Sections 7.21 and 9.03 thereto, DHC Sponsor, LLC.       X   8-K   2.1   September 8, 2023
2.2 # Share Purchase and Transfer Agreement, dated October 29, 2024, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG.       X   8-K   2.1   October 30, 2024
2.3   Addendum to Share Purchase and Transfer Agreement, dated February 6, 2025, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG.       X   8-K   2.1   February 12, 2025
2.4   Addendum II to Share Purchase and Transfer Agreement, dated May 26, 2025, by and among Brand Engagement Network Inc., Christian Unterseer, CUTV GmbH and CUNEO AG.       X   8-K   2.1   May 30, 2025
Certificate of Incorporation and Bylaws                    
3.1   Certificate of Incorporation of Brand Engagement Network Inc.       X   8-K   3.1   March 20, 2024
3.2   Certificate of Amendment of Certificate of Incorporation of Brand Engagement Network Inc.       X   8-K   3.1   December 1, 2025
3.3   Bylaws of Brand Engagement Network Inc.       X   8-K   3.2   March 20, 2024
3.4   Amendment No. 1 to Bylaws of Brand Engagement Network Inc.       X   8-K   3.1   November 28, 2025

 

41

 

 

Exhibit Number   Description of Document   Filed Herewith   Incorporated by Reference   Form   Exhibit No.   Date Filed
Instruments Defining the Rights of Security Holders                    
4.1   Warrant Agreement between Continental Stock Transfer & Trust Company and DHC Acquisition Corp.       X   8-K   4.1   March 5, 2021
4.2   Registration and Shareholder Rights Agreement, dated March 4, 2021, by and among DHC Acquisition Corp, DHC Sponsor, LLC and certain other equityholders named therein.       X   8-K   10.3   March 5, 2021
4.3   Amended and Restated Registration Rights Agreement, dated March 14, 2024, by and among Brand Engagement Network Inc. and the holders party thereto.       X   8-K   10.1   March 20, 2024
4.4   Description of Securities.       X   10-K   4.4   April 16, 2026
4.5   Form of Warrant issued pursuant to the Securities Purchase Agreement, dated May 28, 2024 (included as Exhibit A to Exhibit 10.1).       X   8-K   10.1   May 29, 2024
4.6   Form of Warrant issued pursuant to the Securities Purchase Agreement, dated July 1, 2024.   X                
4.7   Form of Warrant issued pursuant to the Warrant Purchase Agreement, dated August 26, 2024.   X                
4.8   Form of Reload Warrant issued pursuant to the Warrant Exercise and Reload Agreement, dated January 13, 2025.   X                
4.9   Form of Warrant issued pursuant to the conversion agreements, dated December 20, 2025.   X                
Executive Compensation Plans and Agreements                    
10.1 † Brand Engagement Network 2023 Long-Term Incentive Plan.       X   8-K   10.4   March 20, 2024
10.2 † Brand Engagement Network 2023 Long-Term Incentive Plan, Form of Restricted Stock Unit Agreement.       X   8-K   10.5   March 20, 2024
10.3 † Brand Engagement Network 2023 Long-Term Incentive Plan, Form of Nonqualified Stock Option Agreement.       X   8-K   10.6   March 20, 2024
10.4 † Brand Engagement Network 2023 Long-Term Incentive Plan, Form of Restricted Stock Award Agreement.       X   8-K   10.7   March 20, 2024
10.5 † Brand Engagement Network 2023 Long-Term Incentive Plan, Form of Incentive Stock Option Agreement.       X   8-K   10.8   March 20, 2024
10.6 † Blockchain Exchange Network, Inc. 2021 Equity Incentive Plan (Relating to Class B Common Stock).       X   S-1/A   10.8   April 22, 2024
10.7 † Form of Option Agreement under the Blockchain Exchange Network, Inc. 2021 Equity Incentive Plan.       X   S-1   10.9   April 12, 2024
10.8 † Form of Compensatory Warrant.       X   S-1   10.10   April 12, 2024

 

42

 

 

Exhibit Number   Description of Document   Filed Herewith   Incorporated by Reference   Form   Exhibit No.   Date Filed
10.9 † Employment Agreement by and between Brand Engagement Network Inc. and Tyler J. Luck (including the Post-Merger Employment Agreement attached as Exhibit A thereto).       X   8-K   10.13   March 20, 2024
10.10 † Employment Agreement by and between Brand Engagement Network Inc. and Paul Chang, effective May 7, 2023 (including the Post-Merger Employment Agreement attached as Exhibit A thereto).       X   8-K   10.11   March 20, 2024
10.11 † First Amendment to Employment Agreement, dated April 22, 2024, by and between Brand Engagement Network Inc. and Paul Chang.       X   S-1/A   10.14   April 22, 2024
10.12 † Offer Letter, dated November 7, 2024, by and between Brand Engagement Network Inc. and Walid Khiari.   X                
10.13 † Form of Employee Restricted Stock Election Form.   X                
10.14 † Success Fee Agreement, dated June 23, 2026, between the Company and Janine Grasso.   X                
Indemnification Agreements                    
10.15   Form of Indemnification Agreement for directors and executive officers of Brand Engagement Network Inc.       X   8-K   10.2   March 20, 2024
Sponsor Agreements                    
10.16   Letter Agreement, dated March 4, 2021, by and among DHC Sponsor, LLC, DHC Acquisition Corp and its officers and directors.       X   8-K   10.4   March 5, 2021
Financing Agreements                    
10.17   Form of Shareholder Subscription Agreement.       X   8-K   10.3   March 20, 2024
10.18   Subscription Agreement, dated September 7, 2023, by and between Brand Engagement Network Inc. and AFG Companies, Inc.       X   8-K   10.17   March 20, 2024
10.19   Subscription Agreement, dated September 29, 2023, by and between Brand Engagement Network Inc. and AFG Companies, Inc.       X   8-K   10.16   March 20, 2024
10.20   Brand Engagement Network Inc. Convertible Promissory Note, dated April 12, 2024, by and between Brand Engagement Network Inc. and J.V.B. Financial Group, LLC.       X   S-1   10.21   April 12, 2024
10.21   Securities Purchase Agreement, dated May 28, 2024, by and between the Company and certain purchasers identified on the signature pages thereto.       X   8-K   10.1   May 29, 2024
10.22   Letter Agreement to Exercise Warrants, dated May 28, 2024, by and between the Company and certain purchasers identified on the signature pages thereto.       X   8-K   10.2   May 29, 2024

 

43

 

 

Exhibit Number   Description of Document   Filed Herewith   Incorporated by Reference   Form   Exhibit No.   Date Filed
10.23   Securities Purchase Agreement, dated July 1, 2024, by and between the Company and the purchaser identified on the signature page thereto.       X   8-K   10.4   July 5, 2024
10.24 ^ Securities Purchase Agreement, dated August 26, 2024, by and among Brand Engagement Network Inc. and certain purchasers identified on the signature pages thereto.       X   8-K   10.1   August 26, 2024
10.25   Amendment No. 1 to Securities Purchase Agreement, dated October 5, 2024, by and among Brand Engagement Network Inc. and certain purchasers identified on the signature pages thereto.       X   8-K   10.1   October 7, 2024
10.26   Share Assignment and Lockup Release Agreement, dated August 26, 2024, by and among Brand Engagement Network Inc., certain members of DHC Sponsor, LLC, certain other existing stockholders and affiliates of the Company signatory thereto and certain purchasers identified on the exhibits thereto.       X   8-K   10.2   August 26, 2024
10.27 ^ Warrant Purchase Agreement, dated August 26, 2024, by and among Brand Engagement Network Inc. and each of the warrantholders signatory thereto.       X   8-K   10.3   August 26, 2024
10.28   Form of Letter Agreement, dated August 26, 2024, by and among Brand Engagement Network Inc., certain members of DHC Sponsor, LLC and certain other existing stockholders and affiliates of the Company signatory thereto.       X   8-K   10.4   August 26, 2024
10.29 ^ Warrant Exercise and Reload Agreement, dated January 13, 2025, by and among Brand Engagement Network Inc. and certain purchasers identified on the signature pages thereto.       X   8-K   10.1   January 14, 2025
10.30   Line of Credit Agreement, dated June 5, 2025, by and between Brand Engagement Network Inc. and Corps Capital Advisors LLC.       X   8-K   10.1   June 10, 2025
10.31   Conversion Agreement, effective December 17, 2025, by and between Brand Engagement Network Inc. and BEN Capital Fund I, LLC.       X   8-K   10.1   December 18, 2025
Material Commercial Agreements                    
10.32   Exclusive Reseller Agreement (SAAS), dated as of August 19, 2023, by and between Brand Engagement Network Inc. and AFG Companies, Inc.       X   8-K   10.15   March 20, 2024
10.33   First Amendment to Exclusive Reseller Agreement (SAAS), dated February 9, 2024, by and between Brand Engagement Network Inc. and AFG Companies, Inc.       X   S-1   10.17   April 12, 2024
10.34   Form of Reseller Warrant.       X   S-1   10.18   April 12, 2024
10.35 ^ Shareholders Agreement of SKYE Inteligencia LATAM, S.A. de C.V., dated October 30, 2025, by and among Brand Engagement Network Inc., SKYE Inteligencia LATAM, S.A. de C.V. and the other shareholders party thereto.       X   8-K   10.1   November 10, 2025
10.36 ^ Reseller Agreement (SaaS), effective October 30, 2025, by and between Brand Engagement Network Inc. and SKYE Inteligencia LATAM.       X   8-K   10.2   November 10, 2025

 

44

 

 

Exhibit Number   Description of Document   Filed Herewith   Incorporated by Reference   Form   Exhibit No.   Date Filed
Related Party Agreements                    
10.37   Conversion Agreement, dated December 17, 2025, as amended by and between Brand Engagement Network Inc. and BEN Capital Fund I, LLC.   X                
10.38   Loan Agreements between Brand Engagement Network Inc. and each of Corps Cap Diversified Income Fund, Corps Capital BDC, LLC and Corps Cap Advisors, LLC.   X                
10.39   Consulting Agreement, dated June 1, 2023, by and between Brand Engagement Network Inc. and Michael Lucas.   X                
10.40   First Amendment to Consulting Agreement, dated September 26, 2023, by and between Brand Engagement Network Inc. and L5, LLC.   X                
10.41   Second Amendment to Consulting Agreement, dated September 26, 2023, by and between Brand Engagement Network Inc. and L5, LLC.   X                
10.42   Third Amendment to Consulting Agreement, dated September 26, 2023, by and among Brand Engagement Network Inc., L5, LLC and Eleven7 Holdings, LLC.   X                
Insider Trading Policy                    
19.1   Insider Trading Policy.       X   10-K   19.1   March 31, 2025
Subsidiaries of the Registrant                    
21.1   List of Subsidiaries.       X   8-K   21.1   March 20, 2024
Certifications                    
31.1   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   X                
31.2   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   X                
Compensation Recovery Policy                    
97.1   Compensation Recovery Policy.       X   10-K   97.1   March 31, 2025
Interactive Data                     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).   X                

 

# Schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby agrees to furnish a copy of any omitted schedule to the Securities and Exchange Commission upon request.
^ Certain information has been redacted from this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both not material and is the type of information that the registrant customarily and actually treats as private or confidential. The registrant hereby undertakes to furnish supplemental copies of the unredacted exhibit upon request by the Securities and Exchange Commission.
† Indicates a management contract or compensatory plan or arrangement.

 

Item 16. Form 10-K Summary

 

None.

 

45

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BRAND ENGAGEMENT NETWORK INC.
   
Dated: November 19, 2026 By: /s/ Tyler Luck
    Tyler Luck
    Chief Executive Officer

 

46

 

Keep reading